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Abstract 
In hospitalized patients with neutropenia, Candida albicans is the fourth leading cause of 
systemic bloodstream infections, which have a mortality rate of approximately 30 %. The 
phosphatidylserine synthase enzyme of C. albicans, Cho1p, appears to be a good drug target 
as a mutant lacking this enzyme (the cho1∆/∆ [null mutant]) is avirulent in animal models of 
Candida infections and this enzyme is not conserved in humans.  We discovered that the loss of 
phosphatidylserine (PS) synthesis affects C. albicans' expression of the Als3p adhesin, a 
virulence protein, and loss of PS synthesis also compromises the cell wall, causing increased 
exposure of the polysaccharide β [beta]-(1,3) glucan that ultimately leads to increased 
recognition by the immune system.  
Downstream of phosphatidylserine synthase are the decarboxylase enzymes Psd1p and 
Psd2p, which are essential for de novo synthesis of phosphatidylethanolamine from 
phosphatidylserine. When these enzymes are lost, the only option the yeast has to acquiring 
phosphatidylethanolamine is by synthesizing it by the Kennedy Pathway utilizing ethanolamine 
acquired from the environment. The final chapter of my dissertation explores how ethanolamine 
is difficult to acquire from the host in vivo, and is ultimately a bottleneck for C. albicans to cause 
virulence in the mouse model of disseminated candidiasis.  
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Chapter I: Background and Introduction 
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An Overview of Candida albicans Virulence 
 Candida spp. are human commensal fungi that colonize the gastrointestinal tract, as well 
as vaginal and oral mucosa (1). They occur as oral flora for approximately 30-60% of healthy 
individuals and usually do not cause disease (2, 3). However, C. albicans and related species 
are capable of causing more serious systemic infections, where it is present in the bloodstream 
and deep organs, and are of great concern as they have a high associated mortality rate once 
fungal septicemia is established (31.8%) (4). Systemic infections are a common problem in 
intensive care units (ICUs), and are associated with risk factors such as major abdominal 
surgery, catheterization and prolonged stays in the ICU (5). Patients with neutropenia are also 
more susceptible to systemic fungal infections, making patients with leukemia or undergoing 
vigorous chemotherapy treatments generally more susceptible to systemic infections (6, 7). In 
addition, C. albicans is the leading blood-borne fungi to colonize patients’ prosthetic heart 
valves (8). This affliction, which is known as fungal endocarditis, is extremely life threatening 
with a mortality rate of up to 40%, and is difficult to treat with antifungals once established (9, 
10).  
Currently there are only five classes of antifungal drugs available to treat fungal 
infections, and toxicity and resistance limit their effectiveness. Only 3 of the 5 can be used for 
systemic infections, further limiting options for treatment of fungal bloodstream infections (11-
13). The polyenes bind ergosterol in the cell membrane, disrupting cell integrity and resulting in 
cell death. An example is amphotericin B, which is the only polyene that is an effective 
treatment for systemic infections, but must be given intravenously and has the ability to cause 
kidney damage (14, 15). As ergosterol is a lipid that is unique to fungi, it has also been targeted 
by the azole drug family, which inhibits the enzyme lanosterol 14 α-demethylase which converts 
lanosterol to ergosterol. Ultimately inhibition of this pathway results in a lack of ergosterol in the 
fungal cell membrane, and a fungistatic control of infection (16). Apart from targeting of 
ergosterol, cell wall components that are unique to fungi can be targeted, in particular the         
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ß-(1,3) glucan saccharide that is important for cell wall infrastructure. Drugs that belong to the 
echinocandins family (such as caspofungin) are able to inhibit the enzyme β-(1,3) glucan 
synthase, thus causing the cell wall to eventually lose integrity (16). The remaining drugs are 
hydrophobic and can only be used topically for fungal skin or nail infections. For example, 
allylamines are hydrophobic and are not amenable for administration orally or intravenously 
(17).  
In immunocompromised patients Candida spp. are able to cause an extremely common 
oral infection known as oropharyngeal Candidiasis (OPC) (2). OPC is one of the first indicators 
of suppression of adaptive immunity, and is seen in up to 95% of AIDS patients at some time 
during their infection (18). Other risk factors for OPC include use of steroid inhalers and the use 
of dentures, and is becoming a common infection in recipients of solid organ transplants (19-
22).  These infections are deleterious to the comfort of the patient causing difficulty chewing and 
swallowing, and in severe cases will result in reduced eating and weight loss (2). It is important 
to note that these oral infections are refractory to medications and often exhibit drug resistance, 
making treatment challenging (23). Out of all Candida species, C. albicans is the species most 
commonly isolated from oral lesions (24).  
C. albicans morphology and its role in virulence 
Morphology is also known to be involved in C. albicans virulence. Morphology 
differences are dependent on the phenomenon known as "phenotypic switching", which is the 
ability of C. albicans to switch between its 3 forms: yeast, pseudohyphae, and hyphae (Fig. 1.1). 
In regards to virulence, the yeast form is regarded as being important for dispersion and travel 
within the bloodstream, and the hyphal form important for tissue invasion and damage (Fig 1.1) 
(25-28). This is at least partially due to differential gene regulation in the yeast or hyphal forms, 
with the hyphal form expressing specific adhesins as well as secreted aspartyl proteases that 
altogether enable it to become an effective bloodstream pathogen (29-31). Hyphal cells also 
contain up to three times more chitin in comparison to yeast form, which may play a role in 
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immune resistance and robustness in surviving in vivo as it lends strength to the overall 
structure of the cell (32). For instance, C. albicans strains that are upregulated in chitin 
synthesis by upregulation of Pir32 are more virulent than wild type (33). Pir32 is also 
upregulated when C. albicans is phagocytosed by macrophages, which may aid in C. albicans’ 
survival and escape of the macrophage phagosome (34). 
 The importance of hyphal formation of C. albicans for virulence is also demonstrated in 
mutants that are unable to form hyphae. The efg1∆/∆ cph1∆/∆ double mutant is permanently 
fixed in yeast-form and is less virulent, and is reduced in the ability to invade host endothelial 
cells in the mouse oropharyngeal candidiasis model (25). However, there is evidence 
suggesting that hyphal formation is not the end-all and be-all of C. albicans virulence. When the 
hyper-filamentous C. albicans mutant tup1∆/∆ is generated, it is reduced in virulence and 
dissemination (25). Altogether these findings suggest that both yeast and hyphal forms work 
together in concert to disseminate in the bloodstream as well as invade host tissue.  
A Phospholipid biosynthesis overview for fungi and humans 
 Apart from the morphology of Candida albicans, there are a variety of other components 
that can contribute to virulence, such as secreted aspartyl proteases (SAPs), adhesin 
molecules, and phospholipases (35). Inversely, many factors can contribute to a lack of 
virulence for C. albicans including auxotrophy of essential nutrients such as amino acids (36, 
37). As this dissertation is focused on how a loss of phospholipids can result in a loss of 
virulence, and how yeast phospholipid synthesis enzymes could be unique drug targets, it is 
vital to understand how yeast and mammals differ in the steps that it takes to generate these 
various phospholipids. Yeast including C. albicans have two main means of synthesizing 
phospholipids, either by the de novo process or via the Kennedy pathway (Fig. 1.2). The de 
novo pathway is the sole means by which C. albicans can synthesize phosphatidylserine. It 
does so from cytidine diphosphate diacylglycerol (CDP-DAG) and serine by the Cho1p enzyme 
(38). Phosphatidylserine (PS) can then be decarboxylated into phosphatidylethanolamine (PE) 
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by the phosphatidylserine decarboxylases Psd1p (located in the mitochondria) or Psd2p 
(located in the Golgi/vacuole) (39-42). Lastly, phosphatidylethanolamine can then be methylated 
by the two methylases Opi3 and Cho2 to generate phosphatidylcholine (PC), the most abundant 
phospholipid in yeast genera.  
Apart from the de novo pathway, phosphatidylethanolamine and phosphatidylcholine can 
be generated from the Kennedy pathway, which directly incorporates ethanolamine and choline 
into diacylglycerol (DAG) to make their respective phospholipids (Fig.1.2) (41, 43). Synthesis of 
PE or PC via the Kennedy pathway consists of a total of 3 enzymatic steps. First, ethanolamine 
is phosphorylated in an ATP-dependent manner by an ethanolamine kinase. After 
phosphorylation, the enzyme cytidine tri-phosphate (CTP) phosphoethanolamine 
cytidylyltransferase uses the CTP as an energy source to generate (cytidine di-phosphate) 
CDP-ethanolamine. Lastly, CDP-ethanolamine 1,2-diacylglycerol ethanolamine 
phosphotransferase completes the final step of PE synthesis, using CDP-ethanolamine and 
DAG to form PE. Synthesis of PC via the Kennedy pathway requires the same steps, but uses 
choline as the head group substrate instead of ethanolamine.  It has been found however that 
generation of phosphatidylethanolamine via this pathway is limited by the supply of 
ethanolamine in the media, and growth does not become as robust as wild type until exogenous 
ethanolamine is supplied at 1 mM ethanolamine in minimal media (44). 
Phospholipid synthesis and its role in virulence in organisms 
 Auxotrophy is known as the loss of an organism’s ability to synthesize an organic 
compound required for growth, such as essential amino acids, fatty acids, or vitamins (45). 
URA3 (synthesizes uracil), HIS3 (synthesizes histidine), and LYS4 (synthesizes lysine) are 
three examples in which when knocked out in C. albicans, the yeast fails to grow in the absence 
of these amino acids; as these amino acids are not readily available in the host, losses of these 
genes also result in a reduction in virulence in an immune-competent mouse model of systemic 
candidiasis (36, 46, 47). Auxotrophy in C. albicans for the synthesis of oleic acid also makes it 
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more susceptible to the antifungal drug amphotericin B, an important antifungal administered 
intravenously (48). These fatty acids are important for the organism as they are essential for 
synthesizing a variety of compounds within the cell, including phospholipids. Other fungal 
pathogens may also be affected in virulence by auxotrophy. Aspergillus fumigatus, when it is 
auxotrophic for uridine and uracil, is reduced in virulence in a mouse model of invasive 
aspergillosis (37). 
Phospholipid synthesis is an essential function for all living organisms, and when it is 
disrupted there are repercussions, some which can be fatal, and others which have severe side 
effects. For C. albicans, we have discovered that the loss of phosphatidylserine synthase in the 
cho1∆/∆ mutant results in growth defects in minimal media, ethanolamine auxotrophy, 
avirulence and cell wall defects (44). This mutant is also diminished in 
phosphatidylethanolamine (PE) synthesis (a downstream product in the de novo pathway, Fig 
1.2). In addition, the psd1∆/∆ psd2∆/∆ double mutant is comparably diminished in PE levels 
(though not in PS, as the cho1∆/∆ mutant). We have discovered that for both of these mutants, 
the loss of PE is responsible for both of them losing virulence in a mouse model of candidiasis, 
as well as a diminished ability to colonize the oropharynges.  
Interestingly, a role for phospholipids in virulence is not unique to C. albicans and 
defects can occur in other organisms when phospholipid synthesis is compromised. One 
example of phospholipid synthesis being important for virulence is exemplified by the bacterial 
pathogen Brucella abortus, which is a facultatively intracellular bacterium that is responsible for 
causing spontaneous abortions in cattle (a condition known as brucellosis) (49). When PE as 
well as PS synthesis are diminished in a phosphatidylserine synthase mutant (pssA∆), there is 
an increased sensitivity to detergents which indicates altered cell membrane properties (50). 
This mutant was unable to successfully colonize a mouse and had difficulty surviving 
intracellularly in an intro assay, suggesting that PE is essential for virulence (50). In addition, 
Mycobacterium tuberculosis, which is a significant pathogen affecting hundreds of thousands 
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per year with lung infections (51) is diminished in virulence when it is no longer able to 
synthesize inositol, a precursor for phosphatidylinositol (PI) synthesis (52). A loss of this 
essential substrate resulted in a diminished ability to colonize macrophages as well as reduced 
overall lethality in a pulmonary mouse model. PI is an important constituent for the virulence 
factor lipoarabinomannan, which may explain how a loss of PI causes a reduction in virulence 
(52, 53). 
 It has also been discovered that phospholipid synthesis is vital for virulence in a variety 
of eukaryotes, including Plasmodium falciparum, a protozoan parasite that causes malaria in 
humans and is one of the most significant pathogens even to this day (54, 55). It was revealed 
that when phosphatidylcholine (PC) synthesis is inhibited in P. falciparum, it is unable to survive 
in vitro in culture suggesting that it is vital for survival (56). This finding was determined by the 
administration of the PC analog miltefosine, and then measuring the organism’s proliferation 
rate in a blood culture (56). Yet another eukaryote that is influenced by the loss of lipid synthesis 
is Toxoplasma gondii, another obligate intracellular protozoan that is responsible for causing 
toxoplasmosis, a disease that affects an incredibly wide array of warm-blooded animals (57, 
58). The T. gondii fatty acid synthesis II (FAS II) pathway is essential for lipoylation of the 
apicoplast organelle. When this is abolished in the null mutant Acp∆, it is unable to survive in a 
tissue culture plaque assays, and eliminating this enzyme from the pathogen eliminates all 
mortality when injected in the mouse model (59), ultimately suggesting that synthesis of this 
important lipid molecule is vital for the survival of this organism (59). 
 Ultimately the synthesis of phospholipids is vital for avirulence in several microbes.  
Interestingly, despite studies in bacteria and parasites similar studies in pathogenic fungi are 
largely lacking. 
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Importance of adhesins in virulence for C. albicans 
The Als family of adhesins expressed in C. albicans consists of 8 different proteins, that 
are all GPI-anchored cell wall proteins that all generally play a role in adherence to surfaces as 
well as inducing endocytosis by mammalian cells (60). Some of these Als proteins have been 
implicated in virulence: for instance, the Als1p protein has been shown to greatly increase 
adhesion to epithelial cells when artificially expressed in Saccharomyces cerevisiae (61). 
Comparatively, addition of the Als3p protein to S. cerevisiae also increased adhesion to 
epithelial cells to a statistically significant degree (61), and C. albicans that had Als3p removed 
from the genome had a drastically lower level of adherence to epithelial cells (62). 
The cell wall protein Als3p is a virulence factor that acts as an adhesin, invasin, and 
binds host ferritin (31, 63-66), and it is specifically regulated by the transcription factor Rim101p 
which mediates the pH mediated response (67, 68). There is also evidence that ALS1, ALS3, 
and HWP1 are regulated by the Rlm1p transcription factor (69). The Als3p protein is produced 
exclusively on the hyphal form of C. albicans (C. albicans morphology illustrated in Fig. 1.1)(70). 
From an in vivo perspective, this pathway is implicated in virulence as it is activated when C. 
albicans detects the pH neutral bloodstream as well as the presence of serum (67). While Als3p 
does not appear to contribute to virulence in a systemic mouse model of candidiasis, it does 
affect virulence in an tissue culture model of oropharyngeal candidiasis (OPC) using a FaDu cell 
line, as well as a modest role in virulence in the mouse OPC model (31, 71). 
The immune response to C. albicans 
C. albicans inhabits the gastrointestinal (GI) tract primarily as a yeast-form and as a 
commensal does not typically cause disease (72). The intestines are protected from invasion of 
normal flora by the intestinal mucosal barrier, which consists of a physical barrier as well as an 
immunological barrier (part of the initial immunological recognition is mediated by Peyer’s 
patches, which play a part in sensing overgrowth in the GI tract and prevent invasion into the 
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host tissue) (73). This is the first line of defense the host has against the fungus, but can 
become compromised in those who are immunocompromised. If a breach in the physical 
barriers of the host occur, the immune system plays an important role in elimination of C. 
albicans and is critical for the survival of the host. 
The main purpose of the yeast cell wall is to protect it from environmental stress such as 
osmolarity and detect its surroundings, but can also serve an important role in concealing it from 
the immune system (74-76). In systemic bloodstream infections of C. albicans (known as 
candidiasis), the cell wall surface helps conceal C. albicans from recognition from the innate 
immune system by concealing its main pathogen-associated molecular pattern (PAMP) ß-(1,3) 
glucan, which enables the pathogen to disseminate with minimal detection by the innate 
immune system (77, 78). The surface of the cell wall largely consists of a thick layer of heavily 
mannosylated proteins, which conceals/masks the ß-(1,3) glucan underneath (79-81). When the 
innate immune system detects structural ß-(1,3) glucan sugars they elicit a pro-inflammatory 
response, promoting elimination of the infection (82, 83). 
 While the innate immune system predominantly plays a role in systemic infections, the 
adaptive immune response can play a role in mucosal infections, resulting in a pro-inflammatory 
Th1 response (84). Examples of these infections are oropharyngeal candidiasis as well as over 
colonization of the vaginal tract, both which can lead to discomfort to those whom that are over-
colonized.  
Phagocytic effector cells of the innate immune system like neutrophils and macrophages 
are the first line of defense against systemic fungal infections (such as candidiasis). These 
effector cells detect fungi by binding ß-(1,3) glucan  in the fungal cell wall with a C-type lectin 
signaling protein called Dectin-1 that is found on a number of innate immune effector cells, and 
induces production of pro-inflammatory cytokines such as TNFα as well as yeast phagocytosis 
(82, 85, 86). Apart from Dectin-1, there is Dectin-2 which can detect mannan (82, 85).  These 
Dectin receptors are C-type lectin transmembrane receptors (87). Dectin-1 can mediate 
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signaling by itself with a tyrosine-based action motif (ITAM); in contrast, the Dectin-2 receptor 
requires an associated adaptor molecule for ITAM-based activation (88). Once binding of their 
appropriate ligand occurs, these Dectin receptors will be phosphorylated on a tyrosine residue 
by the spleen tyrosine kinase (syk), a protein tyrosine kinase (89). Once phosphorylated, the 
Dectin-1 receptor initiates a signaling cascade that promotes phagocytosis, release of reactive 
oxygen species (ROS) and cytokine release (Fig. 1.3) (89)  
Separately from these fungal-specific receptors, toll like receptors (TLRs) 2 (which 
recognizes phospholipomannan) and 4 (which recognize O-bound mannans) play an important 
role in the innate immune response. While these receptors are able to bind fungal components, 
TLR2 is also able to bind and recognize peptidoglycan, a predominant cell wall component of 
gram + bacteria, and TLR4 is a classical LPS receptor, which makes them versatile signaling 
receptors in the innate immune system (90, 91). Once activated, these receptors associate with 
MyD88 to activate the transcription factor NFκB and results in pro-inflammatory macrophage 
proliferation (92). In addition, some receptors have synergy with one another (such as TLR2 and 
Dectin-1) which together promote phagocytosis by macrophages and a TNFα response (87, 93). 
Lastly, there is the mannose receptor (MR) that recognizes oligosaccharides that terminate in 
mannose and N-acetyl glucosamine (94, 95).  
Apart from effector cells, there are bloodstream components such as defensins and 
histatins that can destroy C. albicans outright based on the surface charge of the microbe (96), 
which may be mediated by either changes in the cell wall, cell membrane, or both. Complement, 
another non-cellular component of the immune system, in particular the C3 component, has 
been implicated in C. albicans colonization of mucosa and may play a role in controlling 
colonization (97). C3b and iC3b in particular can bind to C. albicans, and result in opsonization 
(78). These complement components cannot kill the yeast outright due to their protective thick 
cell wall structure but opsonization mediates recruitment of inflammatory cells (78).In addition to 
C3b, C3d is known to directly bind to β-(1,6) glucan, an important structural component of the 
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cell wall, and binding of these C3 components ultimately results in the recruitment of neutrophils 
to the site of colonization (98). In conclusion, neutrophils are the major component of the innate 
immune system that deals with C. albicans bloodstream infections, with complement and 
macrophages playing a minor role in cytokine production and labeling the C. albicans’ cell wall. 
Due to the fact that our cho1∆/∆ mutant has severe cell wall defects, we were curious as 
to whether this would result in exposure of cell wall components that could be recognized by the 
immune system (44). In Chapter 2, I will discuss how a loss of phosphatidylserine synthesis by 
the cho1∆/∆ mutant results in an increased exposure of β-(1,3) glucan and an increased 
recognition by macrophages. 
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Appendix. Chapter I Figures 
 
Figure 1.1. Representation of the various morphologies that C. albicans can exhibit. A 
yeast form, B pseudo-hyphae form and C Hyphae. Figure from Joseph Chen’s dissertation. 
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Figure 1.2. There are significant differences between humans and C. albicans in the enzyme 
involved in the de novo synthesis of phosphatidylserine (PS).  Cho1p does not have a homolog 
in mammals.  
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Figure 1.3. The Dectin-1 receptor is expressed on the surface of macrophages, dendritic 
cells and neutrophils. The Dectin-1 receptor mediates binding to ß-(1,3) glucan. Normally, 
Candida albicans has a cell consisting of chitin at the base, then ß-(1,3) glucan and ß-(1,6) 
glucan  in the center and the surface is coated with mannoproteins. These mannoproteins 
conceal the glucan underneath, preventing Dectin-1 binding (top part of figure). However with 
certain cell wall mutants, there is a loss of the mannoprotein coat resulting in exposure of 
glucan resulting in binding of the Dectin-1 receptor. This binding induces phagocytosis of the 
bound target, as well as production of the cytokine TNFα as well as reactive oxygen species 
(ROS) (bottom part of figure). Figure adapted from a previous publication (99). 
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Chapter II: ß-(1,3) glucan is unmasked in a phosphatidylserine synthase mutant 
(cho1∆/∆), which leads to an innate immune response mediated by the Dectin-1 receptor 
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Abstract 
The virulence of Candida albicans in a mouse model of invasive candidiasis is 
dependent on the phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE). 
Disruption of the PS synthase gene CHO1 (i.e., cho1∆/∆) eliminates PS and blocks the de novo 
pathway for PE biosynthesis. In addition, the cho1∆/∆ mutant’s ability to cause invasive disease 
is severely compromised. 
The cho1∆/∆ mutant also exhibits cell wall defects, and in this study, it was determined 
that loss of PS results in decreased masking of cell wall β-(1,3) glucan from the immune system. 
In wild-type C. albicans, the outer mannan layer of the wall masks the inner layer of β-(1,3) 
glucan from exposure and detection by innate immune effector molecules like the C-type 
signaling lectin Dectin-1, which is found on macrophages, neutrophils, and dendritic cells. The 
cho1∆/∆ mutant exhibits increases in exposure of β-(1,3) glucan, which leads to greater binding 
by Dectin-1 in both yeast and hyphal forms. The unmasking of β-(1,3) glucan also results in 
increased elicitation of TNF-α from macrophages in a Dectin-1-dependent manner. The role of 
phospholipids in fungal pathogenesis is an emerging field, and this is the first study showing that 
loss of PS in C. albicans results in decreased masking of β-(1,3) glucan, which may contribute 
to our understanding of fungus-host interactions. 
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Introduction 
Both the innate and adaptive immunological responses of the host play a role in 
controlling and eliminating fungal infections, but the innate response is the early responder and 
is crucial for controlling bloodstream infections (100-102). The innate response is mediated 
largely by phagocytic cells such as macrophages and neutrophils, which recognize, 
phagocytose, and kill the pathogen (103). Recognition is dependent, in part, on pathogen-
associated molecular patterns (PAMPs) that are present on the surface of the pathogen, which 
can then be recognized by phagocytic pattern recognition receptors (PRRs) (104-107). Fungal 
cell walls contain the PAMP ß-(1,3) glucan . The fungal wall is composed of two relatively 
indistinct layers; mannosylated proteins (mannan) are enriched on the outer surface layer, and 
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ß-(1,3) glucan  and chitin are enriched in the layer beneath (Fig. 2.2) (108, 109). ß-(1,3) glucan  
is a known PAMP that is recognized by Dectin-1, a C-type lectin PRR that is expressed by 
macrophages, neutrophils, and dendritic cells (104). Several cell wall mutants with increased 
exposure of ß-(1,3) glucan also exhibit increased recognition by phagocytic cells, resulting in 
increased phagocytosis by macrophages and production of cytokines, inducing a strong 
response by the innate immune system that may play a role in the faster elimination of these 
mutants (110, 111). In this communication, we report that the loss of PS in the C. albicans 
cho1∆/∆ mutant results in changes in cell wall structure, notably, an increase in ß-(1,3) glucan  
exposure on the cell surface. The full mechanism of how phospholipids affect the cell wall is not 
known, but it may relate to the manner in which phospholipids like PS modulate signaling 
pathways like calcineurin, protein kinase C, Hog1p, or Cek1p, which regulate the cell wall (112, 
113). Increased ß-(1,3) glucan  exposure induces increased Dectin-1 binding, mediating 
macrophage release of the cytokine tumor necrosis factor alpha (TNFα). The TNFα response is 
important in protecting against systemic candidiasis, and when the TNFα response is ablated by 
either knocking out or neutralizing the TNFα response with an anti-TNFα antibody, mice are 
more susceptible to systemic candidemia (114, 115).  Interestingly, we find that the psd1∆/∆ 
psd2∆/∆ double mutant does not exhibit these phenotypes as strongly, suggesting that PS is 
specifically required for ß-(1,3) glucan  “masking” from immune recognition. 
Results 
Previous work has shown that the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants show poor 
hyphal formation on plates in response to a neutral pH or Spider medium, a medium that is poor 
in nutrients and that promote hyphal formation. However, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants could both form hyphae in response to mouse serum (44). These previous data were 
only qualitative, and it was not clear whether the mutants grew as hyphae at a rate similar to 
that of the wild type in response to serum. Consequently, the hyphal extension rates of the 
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cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants were compared to those of the wild type and psd1∆/∆ 
mutants in human serum by time-lapse microscopy. Through this assay, it was found that all of 
the strains except the cho1∆/∆ mutant exhibited similar hyphal extension rates, with the cho1∆/∆ 
mutant exhibiting a slightly shorter hyphal growth; however the difference was not statistically 
significant (Fig. 2.2 A, Videos A1-4). 
In order to determine if these mutants could also form hyphae in response to more in 
vivo stimuli, such as host tissue, the strains were compared for growth after they infected mice 
and were localized to the kidneys. Each strain was transformed with a construct that would 
express cytoplasmic GFP from the constitutive ENO1 promoter (116). Then yeast-form cells of 
each strain were stained on the exterior with Alexa Fluor 555 dye and administered to mice via 
tail vein injection. Kidney homogenates were analyzed by microscopy 6 h after infection to 
determine if hyphal growth occurred in the kidney. The Alexa Fluor stain allows the identification 
of injected yeast-form cells, and GFP-expressing hyphae that lack Alexa Fluor staining indicate 
new growth after infection of the kidney. Analysis of kidney homogenates revealed that all four 
strains were able to survive and grow similarly within the mouse (Figs. 2.2 B & C). Thus, when 
grown under host-simulating conditions, the mutants appear to form hyphae at a rate similar to 
that of the wild type, at least for several hours. 
Loss of PS results in increased exposure of ß-(1,3) glucan  on the C. albicans yeast-
form cell surface. In a previous report, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants’ cell wall 
defects were studied in the context of yeast-form cells grown at 30°C in rich medium (YPD). In 
these studies, the cho1∆/∆ mutant exhibited stronger cell wall defects than the psd1∆/∆ psd2∆/∆ 
mutant, including a much greater increase in chitin levels than in wild-type cells and a thicker, 
more irregular cell wall, as shown by transmission electron microscopy (44). It was 
hypothesized that these cell wall defects would correlate with phenotypes that impact virulence, 
such as increased exposure of ß-(1,3) glucan , which affects host-pathogen interactions. We 
examined the effects of these mutations on ß-(1,3) glucan  exposure by immunofluorescence 
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with an anti- ß-(1,3) glucan antibody (110). ß-(1,3) glucan  is noticeably more exposed in the log 
and stationary phases of cho1∆/∆  mutant cells than in wild-type, cho1∆/∆::CHO1, psd1∆/∆, or 
even psd1∆/∆  psd2∆/∆ mutant cells (Fig. 2.3 A & B). ß-(1,3) glucan  on the surface of C. 
albicans is bound and detected by Dectin-1, a C-type lectin that is expressed on innate immune 
effector cells such as macrophages, neutrophils, and dendritic cells (110, 117). This binding and 
recognition aids macrophages and neutrophils in the phagocytosis of yeast and results in the 
secretion of cytokines like TNFα (110, 118). Fluorescent staining with sDectin-1–Fc reveals that 
cho1∆/∆ mutant yeast-form cells exhibit greater binding by Dectin-1 than the other strains (Fig. 
2.4 A). Flow cytometry to quantify the binding of sDectin-1–Fc to the surface of yeast-form C. 
albicans supports the microscopy results and indicates that the cho1∆/∆ mutant has significantly 
greater binding by Dectin-1 than the other strains and that the psd1∆/∆ psd2∆/∆ double mutant 
(solid pink line) does not differ from the wild type (black) (Fig 2.4 B). The cho1∆/∆ cells exhibit 
an average increase in binding by Dectin-1 over wild type of approximately 58% (Fig 2.4 C). 
These results support those showing increased anti- ß-(1,3) glucan  staining exposure on the 
cho1∆/∆ mutant cell surface (Fig. 2.4). ß-(1,3) glucan  is bound by Dectin-1, but there are data 
that suggest that anti- ß-(1,3) glucan  antibody and sDectin-1–Fc may bind to somewhat distinct 
epitopes (110). If so, then it should be possible to see co-localization of staining with both 
probes. To assess this, yeast-form cells were double stained with an anti ß-(1,3) glucan  
antibody and sDectin-1–Fc and secondary antibodies with differential fluorophores. It is clear 
that the signals co-localized and are very prominent for the cho1∆/∆ mutant (see Fig. A1). 
Phospholipid mutants generate hyphae when growing in human serum. Since the cho1∆/∆ but 
not the psd1∆/∆ psd2∆/∆ mutant cells exhibit increased exposure of ß-(1,3) glucan  in the yeast 
form, the effects of these mutations on the exposure of ß-(1,3) glucan in hyphae needed to be 
addressed to determine if there were any cell wall differences that are dependent on 
morphology. 
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Loss of PS increases exposure of ß-(1,3) glucan  in hyphae 
The cho1∆/∆ mutant exhibits a greater exposure of ß-(1,3) glucan  than the wild-type, 
psd1∆/∆ psd2∆/∆ double mutant, and other strains in yeast form (Figs. 2.3 A & B, Fig. A1). In 
order to determine if this held true for hyphae as well, cells were grown in human serum at 37°C 
to induce hyphal growth and then stained for ß-(1,3) glucan  exposure with an anti- ß-(1,3) 
glucan antibody.  When staining the C. albicans’ hyphae with sDectin-1–Fc or an anti-ß-(1,3) 
glucan  antibody was performed, only the cho1∆/∆ mutant exhibited strong staining with either 
probe, and the staining, like that in yeast-form cho1∆/∆ mutant cells, was found in overlapping 
patterns (Fig 2.5 A & B, Fig. A2). In addition, a number of the hyphae of the cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants were also malformed compared to those of the wild-type and psd1∆/∆ 
strains They were enlarged at the tips in comparison and in many cases were somewhat curved 
near the tip (Fig. 2.5 A, enlargement indicated by arrows). Approximately 48% of the cho1∆/∆ 
mutant hyphae and 52% of the psd1∆/∆ psd2∆/∆ mutant hyphae showed this phenotype, 
whereas none of the other strains exhibited this phenotype (Table 3). The frequency of co-
localization of anti- ß-(1,3) glucan antibody and Dectin-1 staining was quantified for all of the 
strains, revealing that they bind to unfixed hyphal cells similarly for the most part (Fig. A3). The 
psd1∆/∆ and psd1∆/∆ psd2∆/∆ mutants did have stronger staining than the wild type, but it was 
generally much weaker than that of the cho1∆/∆ mutant strain. Interestingly, for many of the 
mutants staining with sDectin-1–Fc tended to be stronger for the mother yeast cells when they 
were grown in serum (Fig. A2). 
Phospholipid mutants are not more susceptible to killing by innate immune responses. 
As our cho1∆/∆ mutant has increased ß-(1,3) glucan  exposure and increased binding by 
sDectin-1–Fc, it was hypothesized that increased binding of Dectin-1 would result in increased 
susceptibility to killing by macrophages. However, when in vitro killing assays were performed 
with macrophages (RAW264.7 or Raw BLUE), it was found that there was no difference in 
killing for any of the strains (Fig. 2.6 A). Neutrophils are typically more efficient at killing C. 
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albicans than macrophages, so the susceptibility of the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants 
to neutrophils was also tested. However, the mutants were not more readily killed by neutrophils 
either (Fig. 2.6 B). In addition to cellular innate immune responses, it is also possible that the 
mutants might be more susceptible to non-cellular innate immune response elements like 
cationic peptides, as membranes of our cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are defective 
(44). We tested the susceptibility of our mutants to the human cationic peptide β-defensin, which 
is known to act against the negatively charged membranes of invading pathogens and can play 
a role in mucosal defense against C. albicans (96, 119-121). Surprisingly, the cho1∆/∆ mutant 
appeared to be more resistant than the wild type to β-defensin at a concentration of 500 nM, but 
these values were not statistically significant. The psd1∆/∆ and psd1∆/∆ psd2∆/∆ mutants 
showed no differences (Fig. 2.6 C) from the wild type. In addition, the mutants showed no 
difference in binding by complement C (data not shown). 
Loss of PS in C. albicans causes increased elicitation of cytokines from macrophages. 
 Increased exposure of ß-(1,3) glucan  in C. albicans cell wall mutants has been shown to 
cause an increase in TNFα release from macrophages (110). The differences in ß-(1,3) glucan  
exposure reported in the cho1∆/∆ mutant was hypothesized to cause an increase in TNFα 
production. A TNFα-specific ELISA revealed that the cho1∆/∆ mutant elicits greater TNFα 
production from RAW-BLUE macrophages than the wild type strain (Fig. 2.7 A). This is not the 
case for the reintegrant psd1∆/∆, or psd1∆/∆ psd2∆/∆ mutant strain. The Dectin-1 receptor 
expressed on immune effector cells binds to ß-(1,3) glucan  on the C. albicans cell surface, and 
this has been reported to trigger TNFα release (117). Thus, Dectin-1 was presumed to be 
responsible for the increase in TNFα release. In order to rule out other non-Dectin-1 receptors 
as mediators of increased TNFα production by macrophages in response to the cho1∆/∆ 
mutant, an anti-Dectin-1 antibody was administered to the macrophages prior to their exposure 
to cho1∆/∆ mutant cells in order to block Dectin-1 activation during co-incubation with yeast 
cells. The results in Fig. 2.7 A show that blocking of Dectin-1 reduces TNFα production to nearly 
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wild-type levels, revealing that Dectin-1 is responsible for cytokine release. When the RAW 
264.7 macrophage cell line was used, a similar elicitation of TNFα in a Dectin-1-dependent 
manner was observed as well (see Fig. A4). In addition to these data, it was determined that 
there was an statistically significant increase in phagocytosis of the cho1∆/∆ mutant by RAW-
BLUE macrophages after an 8 hour incubation, which is a typical reaction of macrophages to 
yeast in the bloodstream (Fig. 2.7 B) (122). 
Discussion 
Loss of the PS synthase gene CHO1 results in changes in immune recognition, most 
notably, increased exposure of ß-(1,3) glucan  in the cell wall. The increased exposure of β (1-
3)-glucan can be seen from the increased binding of anti- ß-(1,3) glucan antibodies (Fig. 2.3 A & 
B). On the basis of current models, this may be due to glycosylated cell surface proteins on the 
cho1∆/∆ mutant cell wall not adequately concealing the layer of ß-(1,3) glucan  underneath, 
causing “chinks” in the masking of this important yeast cell wall PAMP. These differences in ß-
(1,3) glucan  exposure in the cho1∆/∆ mutant are also supported by Dectin-1 receptor binding to 
both yeast-form (Fig. 2.4 A) and hyphal cells (Fig. 2.5 B) and elicitation of TNFα (Fig. 2.7 A, Fig. 
A4). These data reveal that the immune response to the cho1∆/∆ mutant is stronger than that to 
all of the other strains tested. The more severe defects in immune evasion in the cho1∆/∆ 
mutant (lacks PS and has deficient PE) than the psd1∆/∆ psd2∆/∆ double mutant, which has 
deficient PE but abundant PS, reflect the stronger cell wall deficiencies of the cho1∆/∆ mutant 
(44). The loss of PS for the cho1∆/∆ mutant may also affect the membrane charge of the cell, 
which would reduce the negative surface charge that defensins are known to interact with. This 
may explain why the cho1∆/∆ mutant appears to be more resistant to human β-defensin 2, as it 
has a different surface charge than any of the other strains we tested (Fig. 2.6 C). 
The correlation between increased ß-(1,3) glucan  exposure and increased TNFα 
production in the cho1∆/∆ mutant is notable, as Wheeler and Fink (110) found some mutants of 
Saccharomyces cerevisiae that exhibit increased binding by anti- ß-(1,3) glucan  antibody but 
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did not necessarily bind better to Dectin-1 or hyper-elicit TNFα. Thus, while increased staining 
by anti- ß-(1,3) glucan  antibody does not always correlate with increased immune recognition, 
the increase that occurs in the cho1∆/∆ mutant does yield a more productive immune response 
as well as increased phagocytosis (Fig. 2.7 A & B, Fig. A4). These data suggest that the loss of 
PS alone is responsible for unmasking in C. albicans, and this conclusion is drawn from the 
following observations. (i) Loss of CHO1 results in a complete loss of PS and a 40% drop in PE 
levels, since this population of PE molecules is derived from PS by decarboxylation via Psd1p 
or Psd2p (44). (ii) Loss of PSD1 and PSD2 simultaneously (psd1∆/∆ psd2∆/∆) causes a 40% 
drop in PE similar to that observed in the cho1∆/∆  mutant, but there is an increase in PS, since 
it is not converted to PE by decarboxylation. (iii) Although the cho1∆/∆ and psd1∆/∆  psd2∆/∆  
mutants have similar drops in PE, only the cho1∆/∆ mutant, with its lack of PS, shows a strong 
increase in ß-(1,3) glucan exposure by staining with anti-β (1-3)-glucan antibody or sDectin-1–
Fc (Fig. 2.3 A & B, Fig. 2.4 A, Fig. 2.5 A & B, Figs. A1 & A2) and increased elicitation of TNFα 
from macrophages (Fig. 2.7 A, Fig. A4). Thus, it appears that the loss of PS is responsible for 
the majority of the increased exposure of ß-(1,3) glucan . There is a subtle contrast between the 
hyphal form and the yeast form in regard to ß-(1,3) glucan  exposure. In particular, although 
cho1∆/∆ mutant hyphae have the strongest exposure of ß-(1,3) glucan , the psd1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants also exhibit greater exposure of ß-(1,3) glucan  and binding of 
sDectin-1–Fc than the wild type, but exposure is lower than that of the cho1∆/∆ mutant (Fig. 2.5 
A & B). 
Thus, for hyphae, the defect in masking is affected primarily by PS but is impacted by 
PE as well. We did not test to see if this difference in the hyphal form leads to greater TNFα 
release in macrophages because of technical difficulties when working with hyphae in this 
assay, as they were susceptible to aggregations and hence difficult to distribute evenly to 
macrophages for stimulation to elicit TNFα. Alternatively, these data may indicate that ß-(1,3) 
glucan  is more readily unmasked in the psd1∆/∆ psd2∆/∆ mutant along with the cho1∆/∆ 
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mutant, than in the psd1∆/∆ mutant. This could be of interest, as the unmasking that occurs 
under these conditions correlates with these strains’ defects in virulence. 
The precise defect that leads to increased exposure of ß-(1,3) glucan  in yeast-form cells 
of the PS synthase mutant alone is unclear. This increase does not appear to resemble that of 
the kre5∆/∆ mutant, which has increased exposure all over the cell surface (110). Instead, the 
increased exposure we observe is localized to foci at the periphery of yeast-form cells providing 
a punctate appearance to the exposure (Fig. 2.3 A & B, Fig. A1). These increases also do not 
correlate with bud scars (data not shown). Transmission electron microscopy images of cho1∆/∆ 
mutant cells reveal irregularities in the membrane and cell wall that look like invaginations (44). 
The increased exposure of ß-(1,3) glucan  in the cell wall of the cho1∆/∆ mutant may 
correspond to these irregularities, although that remains to be determined. The mechanism by 
which PS controls β (1-3)-glucan masking could be related to effects of PS on cell wall signal 
transduction pathways, general endocytic trafficking, or alterations of the plasma membrane 
(123, 124). A number of cell wall signaling pathways are directly affected by PS, including the 
protein kinase C (Pkc1p) and calcineurin pathways (125-129). In S. cerevisiae, PS is a cofactor 
for ScPkc1p activity in vitro. In addition, calcineurin is recruited to membranes by PS in vitro. 
Therefore, these pathways could potentially affect the cell wall because of PS loss. The role that 
ß-(1,3) glucan  exposure in the cho1∆/∆ mutant plays in compromising virulence in the host is 
not clear. The yeast form of the cho1∆/∆ mutant elicits a greater release of cytokines from 
macrophages than the psd1∆/∆ psd2∆/∆ mutant and has more exposure of ß-(1,3) glucan  as 
yeast cells or hyphae, suggesting a stronger immune response. However, these mutants are 
pleiotropic, so there are likely other mechanisms at work in addition to unmasking to affect 
virulence. For example, both mutants are ethanolamine auxotrophs (44). Even in YPD, which 
contains ethanolamine, the cho1∆/∆ mutant has a 2.5-fold lower growth rate than the wild type, 
which suggests that the growth rate could play a role in the cho1∆/∆ mutant’s ability to be 
pathogenic; however, it can clearly grow for several hours in serum or in the host (Fig. 2.2 A, B 
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& C), but this may not translate into growth over several days, which is required to overwhelm 
the host during sepsis. Thus, the mutants may not be getting enough ethanolamine to make 
sufficient PE, which is essential (44), as it is in other yeasts like S. cerevisiae and 
Schizosaccharomyces pombe (130). Alternatively, auxotrophy may play a role, but the 
increased exposure of ß-(1,3) glucan  may result in more rapid clearance of the mutant. PS 
clearly affects the cell wall and masking independently of PE, but PE appears to at least subtly 
affect the cell wall in hyphae. These defects compromise an important defensive virulence factor 
of fungi, “masking” of the cell wall PAMP ß-(1,3) glucan. This report sets the stage for a better 
understanding of how PS and PE regulate pathways that ultimately affect virulence traits and 
cell wall physiology in this pathogen. 
Materials and Methods 
Purification of sDectin-1–Fc.  
HEK293T cells were transfected with the soluble Dectin-1–Fc (sDectin-1–Fc) construct 
previously described (131). After selection for stable transfection with Zeocin, the cells were 
seeded into a CELLine AD1000 bioreactor (Wheaton) and cell supernatants were harvested 
twice weekly. Supernatants were purified over Hi-Trap protein A columns (GE Healthcare) and 
dialyzed overnight with phosphate-buffered saline (PBS) in Slide-A-Lyzer Dialysis cassettes 
(Thermo Scientific). Dialyzed supernatants were concentrated with Amicon 
Ultra centrifugal filters (Millipore). Elution from the column directly into 1 M Tris (pH 9) 
neutralization buffer was performed under low-pH conditions with 100mMglycine (pH 2.8). The 
concentration of sDectin- –Fc was determined with the Bradford assay. 
sDectin-1–Fc staining and flow cytometry.  
C. albicans strains were streaked onto YPD agar plates and left at 37°C overnight. A 
single colony per strain was picked and transferred into 5 ml YPD liquid, which was put into a 
rotator wheel and left overnight at 37°C. A sample of culture was centrifuged and washed three 
times with PBS. Samples were blocked in PBS plus 2% bovine serum albumin for 1 hour at 
27 
 
room temperature. After blocking, samples were stained with sDectin-1–Fc at 16.5 µg/ml for 1.5 
h on ice. Samples were washed with PBS five times and then stained with donkey anti-human 
IgG DyLight 488 antibody (Jackson ImmunoResearch) at 0.83 µg/ml for 20 min on ice. Samples 
were washed five times with PBS and then resuspended in 500 µl PBS for flow cytometry. Flow 
cytometry data were obtained for 10,000 gated events per strain, and statistics were calculated 
with the paired Student t test. For imaging, Candida cells were prepared as outlined above but 
were resuspended in 50 µl PBS and visualized with a Zeiss AxioVision Vivotome microscope 
(Carl Zeiss Microscopy, LLC). This experiment was repeated twice. 
In other immunofluorescence experiments with sDectin-1–Fc staining, donkey anti-
human IgG-Cy3 or rabbit-anti-human IgG-Cy2 (both from Jackson ImmunoResearch) was used 
as the secondary antibody. 
Immunofluorescence of ß-(1,3) glucan  and complement.  
Strains were grown overnight in YPD at 30°C. For yeast-form staining, 0.1 optical 
density (O.D) unit of each strain was washed three times with PBS. Blocking and primary and 
secondary antibody incubations occurred on ice in PBS plus 3% bovine serum albumin. 
Blocking was for 1 hour, primary-antibody incubation was for 1.5 hour, and secondary-antibody 
incubation was for 20 minutes with five washes between antibodies. An anti- ß-(1,3) glucan  
antibody (Biosupplies Australia) at a 1:800 dilution was used as the primary antibody, and a 
goat anti-mouse antibody conjugated to Cy3 (Jackson ImmunoResearch) at 1:600 was used as 
the secondary antibody. For hyphal form staining (see Fig. 2.5, Fig. A2), overnight cultures 
grown at 30°C were washed three times with PBS, added to 20% human serum in RPMI in Lab-
Tek glass chamber slides (Thermo Scientific), and incubated at 37°C for 3 hours to ensure 
adequate filamentation. Antibody staining was performed in the same way as yeast-form 
staining. A formaldehyde fixation step with 37% formaldehyde in PBS was used for yeast and 
hyphae in some cases before staining began, and this is noted in the figure legends if that was 
the case. 
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Complement staining with the primary antibody against human C1q-c complement 
(Santa Cruz catalog no. sc-365301) (132) and a Cy3- conjugated anti-mouse secondary 
antibody (Jackson ImmunoResearch) was performed with overnight cultures grown at 30°C that 
were washed three times with PBS. The yeast cells were then incubated with 50% human 
serum for 30 minutes and then stained according to the yeast-form immunofluorescence 
protocol. 
For all immunofluorescence studies, experiments were repeated in triplicate. In each 
experiment, n=100 for yeast cells and 20 for hyphae. 
Quantification of immunofluorescence signal of hyphae for ß-(1,3) glucan  and Dectin-1 
immunofluorescence.  
The fluorescence intensities of labeled hyphae were assessed with NIS-Elements AR 
3.2 image analysis software (Nikon Instruments Inc., Melville, NY). Hyphae were viewed by 
using a rainbow display scale of pixel intensity and assigned a score based on fluorescence 
intensity (red=high [3], yellow=medium [2], green=low [1]. 
Strains and growth media  
All of the strains used for these experiments are described in Table 1 or derived from 
these strains. Strains were cultured in YPD liquid medium (1% yeast extract, 2% peptone, 2% 
glucose) or on YPD agar plates (133). The RAW264.7 mouse-derived macrophage cell line 
(134) and human neutrophils were both cultured in RPMI plus 10% fetal bovine serum and 1X 
penicillin-streptomycin (Gibco). The RAW-BLUE cells that expressed elevated levels of Dectin-1 
were cultured in the same medium as RAW264.7 macrophages, only with the addition of 200 
µg/ml Zeocin (Research Products International Corporation). For the generation of strains that 
express cytoplasmic green fluorescent protein (GFP) constitutively under the control of the 
promoter of the gene for enolase (ENO1), we used the plasmid pENO1-yEGFP3-NAT (116) and 
transformation methods that have been previously described (135). To generate the 
cho1∆/∆::CHO1 reintegrant strain that expresses GFP, the 
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SAT1 marker was flipped out of the CHO1 reintegration construct (pCHO1-SAT1-flipper) (strain 
SED022) and then transformed with the above-described GFP plasmid using nourseothricin 
selection at a concentration of 200 µg/ml (Werner BioAgents). 
Killing assays 
Killing assays were performed with macrophages and neutrophils. Neutrophil isolation 
was done by a method adapted from a previously published protocol (136). Neutrophils were 
obtained from whole blood from a human donor. The blood was diluted with an equal volume of 
PBS, Lymphocyte Separation medium (BioWhittaker) was underlaid, and the cells were 
centrifuged to pellet neutrophils and erythrocytes. The pellet was subjected to 3% dextran 
sedimentation to isolate neutrophils and further treated with 0.2% sodium chloride to lyse any 
residual erythrocytes. Yeast-form cells (from an overnight culture grown in YPD) and 
phagocytes were co-incubated at a 1:40 ratio for 2 hours at 37°C and 5%CO2, and afterward, 
yeast cells were plated on YPD plates for total colony form units (CFU) counting. The 
experiment was performed three separate times, and for each strain in an individual experiment, 
n=5, for a total of n=15 for each strain. 
ELISA of TNFα 
RAW264.7 macrophages were plated the day prior at 5*105/well in a 24-well plate. 
Macrophages and UV-killed yeast-form Candida cells were co-incubated at a 1:10 ratio for 8 h 
at 37°C and 5%CO2. The enzyme-linked immune-sorbent assay (ELISA) kit instructions of the 
manufacturer (R&D Systems) were followed. To determine if the release of TNFα was due to 
Dectin-1 binding, a commercial anti-Dectin-1 neutralizing antibody (InvivoGen MAb-mDect) was 
administered to the macrophages for 1 h prior to co-incubation at a concentration of 100 ng/ml. 
Three individual experiments were performed. For each of these experiments, three individual 
wells were stimulated for 8 hours with the RAW 264.7 macrophage cell line or for 4 hours when 
RAW-BLUE macrophages were used (For RAW-BLUE the setup for the experiment was the 
same). From each well, the sample was taken and measured in triplicate, for a total of nine data 
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points per group. Statistical analysis of the data was performed by the unpaired-sample t test 
with two-tailed P values. The RAW 264.7 macrophages were a gift from Dr. Chunlei Su at the 
University of Tennessee, and the RAW-BLUE were a gift from Dr. Robert Wheeler at the 
University of Maine. 
β-Defensin Assay 
By using a protocol adapted from reference (137), strains were grown overnight in YPD 
at 30°C, washed with 10 mM sodium phosphate buffer (NaPB), and counted with a 
hemacytometer and 105 cells were incubated with various concentrations of human β-defensin 3 
(AnaSpec catalog no. 60741) for 1 hour in 10mMNaPB in a shaking incubator at 37°C. After 
incubation, cells were washed with 10 mM NaPB, diluted 1:100, and plated for CFU counting. 
The assay was performed three separate times. For each strain in each assay, n = 4. Statistical 
analysis of the data was performed by the unpaired-sample t test with two-tailed p-values. 
Time-lapse microscopy of hyphal formation 
A 2% agarose gel was overlaid on the surface of a Delta T dish (Bioptechs, Inc.) with 
wells formed in the gel to contain medium and yeast. Strains were grown overnight in YPD at 
30°C and washed with PBS, and cells were counted with a hemacytometer. RPMI plus 25% 
human serum was added to the wells, and 5 *103 yeast cells were added to each well. The 
Delta T dish was placed on a heated stage set to 37°C and imaged automatically to determine 
hyphal length over a 3 hour period. Hyphal length was determined by software analysis (NIS-
Elements version 3.1; Nikon Instruments). Quantification was performed by monitoring 20 cells 
of each strain. 
In vivo hyphal formation 
GFP-expressing strains were washed with PBS and stained with Alexa Fluor 555 
(Invitrogen) in 100 mM NaCO3 buffer (pH 10) for 30 minutes at room temperature. After cells 
were washed three times in PBS, 107 cells were injected per mouse via the tail vein. After 6 
hours, the mice were sacrificed and their kidneys were removed and immediately homogenized 
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with a Dounce tissue homogenizer and visualized by microscopy. This experiment was 
performed in triplicate with two or three mice per genotype, so there were eight or nine mice per 
strain. For each experiment, both kidneys of each mouse were homogenized together and 
visualized to look for yeast cells. A minimum of 3 cells from each pair of kidneys were imaged, 
for a minimum of 24 to 27 cells of each strain. 
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Appendix. Chapter II Figures 
 
 
Figure 2.1. The structure of the fungal cell wall with the different polysaccharide and 
protein components depicted. (Image adopted from science.kennesaw.edu/fungalcellwall) 
(adapted by Anthony Montedonico, in dissertation at UTK). 
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Figure 2.2. Hyphal formation of the cho1∆/∆ mutant is not significantly impaired in serum 
or host tissue.  A  C. albicans strains were incubated in 100% human serum and were 
observed by time lapse microscopy on thermally regulated glass slides. After 3 hours the length 
of the hyphae was measured as an indicator of growth over time. B  C. albicans strains 
expressing GFP were stained with Alexa Fluor dye during yeast form growth.  Stained yeast 
cells were then injected into mice via the tail-vein and after 6 hours mice were sacrificed, 
kidneys were removed, and then homogenized and viewed by microscopy.  Hyphae expressing 
GFP indicate new growth that occurred within the mouse tissue. C Percentage of yeast 
inoculated in vivo that generated hyphae in the kidneys. 
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Figure 2.3.  A The stationary-phase and log-phase yeast form of the cho1Δ/Δ mutant 
exhibits increased exposure of ß-(1,3) glucan . A Immunofluorescence using an anti-ß1,3-
glucan primary antibody reveals that the cho1Δ/Δ mutant has increased ß-(1,3) glucan  
exposure in comparison to the other strains in both stationary phase (A) and log-phase (B). 
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Figure 2.4. The cho1Δ/Δ mutant in yeast form has increased binding to the Dectin-1 
receptor.  A C. albicans strains grown overnight in YPD were stained with sDectin-1-Fc and 
fluorescently labeled secondary antibody, showing that the cho1Δ/Δ mutant exhibits greater 
staining than all other strains.  B Flow cytometry reveals that the cho1Δ/Δ mutant has greater 
binding to the Dectin-1 receptor in comparison to other strains. C A graph of average mean 
fluorescent intensity from each sample reveals that the cho1Δ/Δ mutant exhibits significantly 
greater staining with sDectin-1-Fc than the other strains. * p-value < 0.05.  
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Figure 2.5. The hyphal form of the cho1Δ/Δ mutant has increased exposure of ß-(1,3) 
glucan  and binding by the Dectin-1 receptor. A Immunofluorescence of ß-(1,3) glucan  
exposure using a anti-ß1,3-glucan antibody reveals that the cho1Δ/Δ mutant and the psd1Δ/Δ 
psd2Δ/Δ double mutant have increased ß-(1,3) glucan  exposure in comparison to the wild type 
and psd1Δ/Δ mutants. This exposure appears to localize at malformed tips of the hyphae 
(indicated by arrows). B Immunofluorescence using sDectin-1-Fc and secondary antibody 
shows that the cho1Δ/Δ mutant exhibits greater binding to Dectin-1 than the other strains.  
WT cho1∆
∆ 
cho1∆∆::CHO1 
psd1∆∆ psd1∆∆ 
psd2∆∆ 
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Figure 2.6. There are no differences in killing by phagocytes or defensins. A RAW 264.7 
macrophages and C. albicans cells were co-incubated for 8 hours and C. albicans plated to 
measure viable CFUs.  C. albicans strains mock challenged with macrophages were used to 
calculate the percentage of C. albicans killed. B Neutrophils were measured for their ability to 
kill the different strains using the same approach as in A, except that they were co-incubated for 
only two hours.  C The cho1Δ/Δ mutant was incubated with ß-defensin or a mock challenge and 
then viable CFUs were measured. No values were statistically significant from one another. 
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Figure 2.7. The cho1Δ/Δ mutant elicits TNFα from macrophages in a Dectin-1-dependent 
manner.   A The TNFα-specific ELISA was used to measure TNFα elicited from RAW-BLUE 
macrophages (Invitrogen) in response to C. albicans challenge after 4 hours. Pre-treatment with 
anti-Dectin-1 neutralizing antibody reveals that the TNFα response is Dectin-1 mediated. B The 
cho1Δ/Δ mutant was more efficiently phagocytosed by RAW-BLUE macrophages in comparison 
to wild type and other strains. 
*  p-value < 0.0001 
† p-value < 0.05 
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Chapter III: The loss of de novo phosphatidylserine and phosphatidylethanolamine 
results in reduction of the adhesin Als3p and downstream virulence factors 
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Abstract 
The Candida albicans mutants cho1∆/∆ (phosphatidylserine synthase) and psd1∆/∆ 
psd2∆/∆ (phosphatidylserine decarboxylase) are avirulent in a mouse model of systemic 
candidiasis.  In this chapter, we find that the mutants are also avirulent in a mouse model of 
oropharyngeal candidiasis (OPC). Given that the cho1∆/∆ mutant has cell wall defects and ß(1-
3)-glucan unmasking (explored in Chapter II) but the psd1∆/∆ psd2∆/∆ mutant did not indicated 
that there may be other phenotypes more associated with a loss of offensive virulence factors.   
There a variety of cell wall proteins expressed by C. albicans that are important for 
virulence in the oropharyngeal candidiasis (OPC) model. One of these proteins is Als3p, an 
adhesin that binds to cadherins, promotes attachment to epithelial and endothelial cells and 
induces endocytosis and tissue damage. The mutants were examined for defects in Als3p and it 
was found that both mutants poorly expressed Als3p on the cell surface. This correlated with 
defects in adhesion to epithelial cells as well as endocytosis by, and damage to, epithelial cells.  
Interestingly, the mutants did not show defects in other adhesins like Als1p or Hwp1p, 
suggesting a specific regulation of the adhesin Als3p.   
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Introduction 
Als3p is an adhesin that belongs to the Als adhesin family of C. albicans and is 
expressed exclusively on hyphal C. albicans (1, 60, 138-140). Adhesins play a key role in 
epithelial cell adhesion, which is a key feature in the establishment and progression of 
Oropharyngeal Candidiasis (OPC) (141-143). Als3p mediates adhesion by binding cadherins on 
the surface of epithelial and endothelial cells (31, 66). This binding induces endocytosis, 
enabling the hyphae to enter the host tissue and cause damage.  When ALS3 is knocked out C. 
albicans has a reduced ability to attach to oral epithelial cell lines and cause tissue damage in 
mice (31, 62). 
The de novo pathway for synthesizing the phospholipids phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) is required for the virulence of C. albicans in a mouse model of 
systemic Candidiasis (44).  The first step of the de novo pathway (Fig 1.2), carried out by the PS 
synthase Cho1p, which generates PS from cytidyldiphosphate-diacylglycerol (CDP-DAG) and 
serine, is responsible for synthesizing all PS within the cell.  PS is also a substrate for PE, 
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where the PS is decarboxylated by the PS decarboxylase enzymes Psd1p and Psd2p. When 
Cho1p or both Psd1p and Psd2p are knocked out, there is a comparable loss of PE to about 
half of wild type levels (44).  The remaining PE is synthesized via the Kennedy pathway from 
diacylglycerol (DAG) and ethanolamine that is primarily imported from the environment (Fig. 
1.2).  In fact, the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are ethanolamine auxotrophs that 
cannot make sufficient PE via the Kennedy pathway without importing ethanolamine. 
Here we describe how loss of PE synthesis through PS synthase (cho1∆/∆) or PS 
decarboxylase (psd1∆/∆ psd2∆/∆) mutations results in a reduction in Als3p and Als3p-
associated virulence phenotypes such as epithelial adhesion and damage. 
Results 
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit cell wall defects (44).  As PE is the 
donor for ethanolamine-phosphate moieties required for glycosylphosphatidylinositol (GPI) 
anchor synthesis (82, 144), we hypothesized that this may lead to poor expression of GPI-
anchored proteins at the cell surface of hyphae. Many cell wall adhesins are GPI-anchored 
proteins, so we assessed whether GPI-anchored adhesins associated with hyphae were 
compromised in the mutants compared to wild-type using monoclonal antibodies.  Analysis of 
the Als3p expression on the cell surface was assessed by immunofluorescence, revealing that 
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit lower levels of Als3p on hyphae, with the 
lowest levels of fluorescence associated with the cho1∆/∆ mutant (Fig. 3.1 A). In addition, there 
were fewer cho1∆/∆ and psd1∆/∆ psd2∆/∆ cells expressing detectable Als3p compared to wild-
type (Fig. 3.1 B). These original findings support our hypothesis that a loss of PE would 
ultimately result in a loss of GPI anchored proteins. The loss of Als3p suggested the possibility 
that other GPI-anchored adhesins were also diminished in hyphae, which may help explain 
decreased virulence and unmasking reported in chapter II.  However, examination of Als1p, 
Als4p, and Hwp1p using immunofluorescence revealed no differences between strains (Fig. 3.2 
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A & B & data not shown).  This suggested that the Als3p expression defect is not due to a 
general defect in GPI-anchored protein processing or hyphal protein distribution, but a 
consequence of reduced Als3p expression.   
As Als3p expression is associated with adhesion to mammalian cell lines, we tested if 
the loss of Als3p expression would correlate with a loss in adhesion to the Chinese hamster 
ovary (CHO) cell line, which is used as an in vitro model for epithelial cell adhesion.  It was 
found that the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants both exhibit reduced adhesion to CHO 
cells (Fig 3.3), which is correlated with the decrease they exhibit in Als3p expression (Fig. 3.1 A 
& B).  
Als3p acts as an invasin that induces endocytosis of C. albicans hyphae into cell lines 
that express cadherins, such as FaDu oral epithelial lines, and mutants that lack ALS3 have 
decreased endocytosis (31).  When C. albicans strains are co-incubated with the FaDu cells, 
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants show reduced endocytosis (Fig 3.4 A).  C. albicans 
cells that have been endocytosed can subsequently damage epithelial cells which can be 
measured by the level of lactate dehydrogenase (LDH) released into the media.  As predicted, 
the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants have lower LDH released into the media (Fig 3.4 B).  
Als3p is not required for virulence in a systemic model of infection (71), however it has 
been shown to play a minor role in OPC (145). In order to investigate if the cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants exhibit a loss of virulence in oropharyngeal infection, a mouse model 
of OPC was performed (146). There was a decrease in pathogenicity for both the cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants in OPC infections (Fig. 3.5 A & B).  The cho1∆/∆ and psd1∆/∆ 
psd2∆/∆ mutants both showed decreased colonization of the tongues of mice based on 
recovered colony forming unit counts (CFUs).  The mutants also had decreased levels of 
colonization on the epithelium as can be seen by histology (Fig 3.5 C). 
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Discussion 
ALS3 expression is controlled by phospholipid levels 
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants have both a qualitative and quantitative 
decrease in the adhesin Als3p (Fig. 3.1 A & B), which is a virulence factor in the mouse model 
of OPC (145). Loss of Als3p results in a decrease in adhesion to CHO and FaDu cell lines, 
which correlates with a loss in damage to, and endocytosis by, epithelial cells (Fig. 3.4 A & B). It 
is important to note that this decrease is specific to Als3p, and there are no deficiencies in the 
immunofluorescence of other adhesins such as Als1p and Als4p (Fig. 3.2 A & B). This led us to 
believe that decreased PE results in a reduction of Als3p immunofluorescence, and this 
reduction is more prominent when PS as well as PE are reduced in the cho1∆/∆ mutant.   
We hypothesize that the loss of these phospholipids affects signal transduction cascades that 
control the regulation of Als3p.  We currently do not know which pathways are involved.  One 
pathway known to be important in the specific Als3p regulation is the pH sensing pathway which 
is mediated by the transcription factor Rim101. This is dependent on proteolytic cleavage and 
activation of Rim101 in response to neutral pH in a cascade that depends on endosomal 
trafficking components (147-152). However, Western blots comparing our mutants to wild type 
showed that there are no differences in Rim101p processing in these strains (Fig. 3.6). It is 
important to note that there may be other pathways dependent on PS and/or PE that are 
regulating ALS3 expression.  For example, Protein kinase C (Pkc1p) in  the cell wall integrity 
MAP kinase pathway depends on PS in S. cerevisiae (66).  
Materials & Methods 
Strains and media 
The C. albicans strains used in this study are in Table 1.  The media used for most 
experiments for growth and maintenance of the strains was YPD (yeast extract, peptone, and 
dextrose) liquid media and plates.  For growth curves, we used minimal media (yeast nitrogen 
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base, dextrose) ± ethanolamine.  The AtSDC strains were generated as follows:  First, the 
AtSDC gene was codon optimized by site-directed mutagenesis in the yeast expression vector 
pVT103-U (153), and was then PCR amplified with SDO17 and SDO18 which introduced NcoI 
and BglII sites that were used to replace the dTomato gene found between these sites in the 
pENO-dTomato-NATr plasmid (154), creating the plasmid pENO1-AtSDC.  This plasmid was 
linearized with EcoRV, and then transformed by electroporation as previously described (44). 
Generation of the Rim101-V5 strains 
Rim101p was tagged with V5 in our strains using the pYLC314.1-RIM101-V5 plasmid, 
which was created as follows. A vector carrying the SAT1 marker, pYLC314, was created first.  
pYLC314 was created from pBluescript II SK+ by cutting it with EcoRI and ligating into it a 1.7kb 
fragment containing the SAT1 marker followed by the C.albicans MET3 promoter.  This 
fragment was generated by PCR from pYLC229 (155) using primers JCO165 and JCO166 that 
introduced EcoRI sites on both flanks (see Table 2).  The MET3 promoter was removed by 
cutting pYLC314 with PstI, which cut on either side of the MET3 promoter and then re-ligating to 
create pYLC314.1.  The C. albicans RIM101 gene, plus 1000 base pairs (bps) of upstream DNA 
and 240 bps downstream, was amplified with primers TRO892 and TRO893, which introduced 
ApaI and XhoI sites respectively, and was cloned into plasmid pYLC314.1 to create pLYC314.1-
RIM101; for primer sequences see Table 2.  A V5 epitope tag was added to RIM101 at the 
internal AgeI site (147) by digesting the plasmid with AgeI and BstBI to remove a segment of 
RIM101, which was replaced by a fragment that was identical except that a V5 tag was added 
just after the AgeI site.  This was done by amplifying the RIM101 sequence with primers SD22, 
which introduced the V5 tag, and SDO20. pYLC134-RIM101-V5 was linearized with BstBI and it 
was transformed into C. albicans strains by electroporation (135). 
Endocytosis of Candida albicans into epithelial cells 
Endocytosis was measured as previously described (31). 
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LDH Release 
The day prior to the experiment, FaDu cell were plated at 5*105 cells/well in a 24 well 
plate in HBSS media + 10% FBS. The next day, media was replaced with fresh HBSS + 2% 
human serum. C. albicans cells were added to wells at an M.O.I. of 5 and co-incubated for 6 
hours at 37ºC + 5% CO2. At this time supernatant was harvested and LDH release was 
quantified using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega, Cat# G1782). 
Adhesion Assay to epithelial cells 
The day prior to the experiment, 4*105 Chinese hamster ovary (CHO) cells/well were 
plated in a 6 well plate with F12 media + 10% FBS + penicillin/streptomycin. The next day, 6*105 
C. albicans cells from an overnight culture grown in YPD were washed 3X with 1mL of PBS and 
resuspended in 9mL complete F12 media in a glass test tube. These were incubated at 37°C for 
1 hour in the shaking incubator. After 1 hour, media was removed from the CHO cells and 3 mL 
of the F12 yeast mixture were added to each well. These plates were returned to 37°C and 
incubated for 2 hours (no shaking). After incubation, media was removed from the wells which 
were washed 5X with 3 mL PBS. Once washing was complete, 3mL of water was added to each 
well in order to lyse the CHO cells. After 10 minutes, the bottom of the plates were scraped with 
a cell scraper to release remaining Candida. This cell mixture was then diluted 1:10, then 100 µl 
of diluent was plated onto YPD + 1M sorbitol plates and incubated overnight at 37°C for 24 
hours. Colony forming units were then counted to determine CFU/ml. 
Western Blot for Rim101p-V5 detection 
Overnight cultures were diluted to 0.1 OD in 50 mL YPD and incubated for 3 hours in 
30°C shaking incubator. After 3 hours, cells were stimulated with M199 media at a pH of 8 for 
30 minutes in 30°C shaking incubator. After stimulation cells were pelleted by centrifugation at 
3300rpm for 3 minutes then the pellet was resuspended in 250 µl PBS with protease inhibitors 
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(Roche cat# 4693124001) and bead beaten 3 times for 30 seconds each. Samples were spun 
down at 2000rpm and the supernatant was measured by Bradford and resuspended in Laemmli 
loading buffer. 20µg protein was run on an 8% acrylamide gel and transferred to PVDF 
overnight. Blocking was 1 hour in TBST + 5% milk, primary was 1:2000 dilution of V5 antibody 
conjugated to HRP (Abcam cat# ab1325) overnight. After primary, the blot was washed 3X 
quickly with TBST then 2X at 5 minutes each with TBST. Western blot was developed with 
Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific cat # 34080). 
Oropharyngeal Candidiasis Model  
This experiment was adapted from a previous publication (145, 146). 
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Appendix. Chapter III Figures 
 
  
Figure 3.1. Mutants reduced in virulence are diminished in Als3p. A The cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants are reduced in Als3p measured by immunofluorescence. B 
Quantification of the number of cells in the population with detectable Als3p. * Comparing WT to 
cho1∆/∆, p-value < 0.0005     ** Comparing WT to psd1∆/∆ psd2∆/∆, p-value <0.005 
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Figure 3.2. The Als1p (A) and Als4p (B) adhesins are expressed equally among the 
phospholipid mutants and wild type.
50 
 
 
Figure 3.3. Loss of Als3p correlates with a loss of adhesion to the CHO cell line. The 
cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are both reduced in the ability to attach to mammalian 
epithelial cells. * p-value< 0.0001 compared to WT.
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Figure 3.4. Mutants reduced in Als3p are also reduced in ability to induce endocytosis 
and tissue damage. A After co-incubation of C. albicans with FaDu cells and then 
counterstaining to visualize endocytosis, it was shown that for the cho1∆/∆ and psd1∆/∆ 
psd2∆/∆ mutants there is a reduction in endocytosis by the epithelial cell line. B  The cho1∆/∆ 
and psd1∆/∆ psd2∆/∆ mutants are both reduced in their ability to cause damage to the FaDu 
cells, indicated by the reduction in lactase dehydrogenase (LDH) release. * p-value< 0.005,   † p-
value< 0.05, ** p-value< 0.0005 †† p-value< 0.001, all compared to WT. 
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Figure 3.5. The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are attenuated for virulence in 
OPC in mice. A, B. Mice were inoculated orally with C. albicans strains, and after five days, 
their tongues were harvested, and the CFUs/gram of tissue were measured.  C. PAS (periodic 
acid-Schiff) staining of histological samples from a clipping of tissue from tongues in A and B is 
shown for each strain.   * = P-value < 0.0002, Compared to WT. 
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Figure 3.6. There are no differences in the proteolytic processing of the Rim101p 
transcription factor. Activation of the Rim101p transcription factor is the same for all strains, 
indicating that Als3p regulation is mediated by another means. YPD is a neutral pH of 6.7 and 
does not activate the pathway. “8” in the figure denotes M199 media adjusted to the pH 8 which 
activates Rim101p proteolytic cleavage. 
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Chapter IV: Ethanolamine auxotrophy is responsible for avirulence in the cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants  
  
55 
 
Abstract 
Candida albicans null mutants in the de novo synthesis of phosphatidylserine (cho1∆/∆ 
mutant) and phosphatidylethanolamine (psd1∆/∆ psd2∆/∆ mutant) are greatly reduced in 
virulence in both a systemic infection model and an oropharyngeal model of Candidiasis. The 
cho1∆/∆ mutant is unable to synthesize phosphatidylserine (PS) and is reduced in 
phosphatidylethanolamine (PE), whereas the psd1∆/∆ psd2∆/∆ mutant is only diminished in PE 
and has elevated levels of PS. Due to the loss of the de novo pathways, both mutants are 
ethanolamine auxotrophs. It was unclear if ethanolamine auxotrophy was the major contributor 
to this loss of virulence, or whether the attenuation in virulence was due to cell wall defects or 
cell signaling.    
 In order to delve into what factors were contributing to avirulence, we tested the 
hypothesis that the main defect in virulence was because on an inability to grow in the host due 
to ethanolamine auxotrophy. These mutants require 1mM ethanolamine in culture media for 
growth and host ethanolamine is estimated at ~30µM.  This hypothesis was tested by supplying 
ethanolamine to the mutants through expression of the Arabidopsis thaliana serine 
decarboxylase (AtSDC), which converts cytoplasmic serine to ethanolamine for PE synthesis by 
the Kennedy pathway.  The AtSDC completely restored ethanolamine prototrophy and virulence 
in the mice, indicating that ethanolamine auxotrophy is the main cause of avirulence in cho1∆/∆ 
and psd1∆/∆ psd2∆/∆ mutants.  
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Introduction 
The de novo pathway for synthesizing the phospholipids phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) is required for the virulence of C. albicans in a mouse model of 
systemic Candidiasis (44). The first step of the de novo pathway, carried out by the PS synthase 
Cho1p, is responsible for synthesizing all PS within the cell. This PS is also a substrate for PE in 
the de novo pathway, where the PS is decarboxylated by the PS decarboxylase enzymes 
Psd1p and Psd2p (Fig. 1.2). When Cho1p is knocked out (the cho1∆/∆ mutant) or both Psd1p 
and Psd2p are knocked out (the psd1∆/∆ psd2∆/∆ mutant), there is a comparable loss of PE by 
about half of wild type levels (44). 
Both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants are ethanolamine auxotrophs, and 
cannot grow in minimal media without ethanolamine (44). It was unclear whether this 
auxotrophy is the major contributor to the loss of virulence, or whether the loss of PS and/or PE 
resulted in other problems (i.e. cell signaling, cell wall perturbations) that would be the major 
contributor to virulence. These were of concern due to the fact that the cho1∆/∆ mutant exhibits 
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cell wall defects that results in ß-(1,3) glucan exposure and elicitation of TNFα from 
macrophages, which could at least play a part in immune activation and elimination in vivo (83).  
Due to the fact that the psd1∆/∆ psd2∆/∆ mutant does not have cell wall defects, but has 
reduced PE levels comparable to the cho1∆/∆ mutant and is avirulent, we suspected that an 
inability to acquire sufficient ethanolamine in vivo to synthesize PE via the Kennedy Pathway 
could be a major contributor to the inability to survive in the host.  In order to assess survival, we 
performed short-term assays an in vitro measure of hyphal length generation in human serum, 
as well as an in vivo mouse experiment (Fig 2.2). These assays revealed that at least for a short 
period of time the mutants were able to generate hyphae. However, we later speculated that 
hyphal generation could be due to the cell using ethanolamine that had been stored in the cell 
and did not reflect what would occur during a long-term infection. Therefore our goal was to 
determine whether the mouse could provide enough ethanolamine to the cho1∆/∆ and psd1∆/∆ 
psd2∆/∆ mutants to support growth. 
In order to investigate this question, we increased levels of endogenous ethanolamine 
by addition of the Arabidopsis thaliana serine decarboxylase gene, which decarboxylates serine 
to ethanolamine (Fig. 1.2). This ethanolamine can then be used by the Kennedy pathway to 
generate PE (Fig. 1.2). With this new means of making PE, the virulence of Candida albicans 
was restored for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants in a mouse model of systemic 
infection. This suggests that our attenuated mutants are unable to acquire sufficient levels of 
ethanolamine inside the host during infection, resulting in an inability to proliferate and cause 
disseminated disease. Altogether our findings indicate that PE is a virulence factor of C. 
albicans that can be targeted potentially by targeting activity of the Cho1p (phosphatidylserine 
synthase) enzyme, reducing virulence and making Cho1p an excellent drug target. 
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Results 
Loss of de novo PE synthesis compromises virulence through ethanolamine auxotrophy 
The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants share a comparable loss in PE and are both 
ethanolamine auxotrophs (44), so we hypothesized that the reason for the loss of virulence is 
due to an inability to acquire sufficient amounts of ethanolamine for PE synthesis by the 
Kennedy pathway within the host.   The level of ethanolamine in the host is estimated to be 
~30µM, but the level required to support growth in culture media is greater than 100µM (44, 
156).  A full understanding of how the loss of PS and de novo PE contribute to avirulence and 
interfere with host-pathogen interactions will aid in the development of assays to search for 
future inhibitors that can be used in drug development, or will reveal other alternative drug 
targets which may also be exploited. 
In order to test this hypothesis, a serine decarboxylase enzyme derived originally from 
Arabidopsis thaliana (AtSDC) was expressed in our C. albicans strains after codon optimization 
(153, 157). AtSDC decarboxylates serine to ethanolamine within the cytoplasm, and the 
ethanolamine can then be used by the Kennedy pathway to synthesize PE (Fig. 4.1). If 
ethanolamine auxotrophy is mediating the loss of virulence, addition of this enzyme should 
restore ethanolamine prototrophy and virulence in a mouse model of systemic Candidiasis.  
The ability of AtSDC to restore ethanolamine prototrophy in the cho1∆/∆ and psd1∆/∆ 
psd2∆/∆ strains was tested by measuring growth in minimal media +/- ethanolamine (Fig. 4.2 A 
& B). As expected, the mutants that exhibited ethanolamine auxotrophy in the past were unable 
to grow in the absence of ethanolamine. When grown in media lacking ethanolamine, the 
transformed mutants expressing AtSDC grew at rates similar to the respective parental mutant 
strains in the presence of ethanolamine (Fig. 4.2 A & B). In addition, thin layer chromatography 
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(TLC) confirmed that PE levels were restored in the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants 
when AtSDC is expressed, even when grown in the absence of ethanolamine (Fig. 4.2 C).  
We then examined if addition of AtSDC would restore virulence for the cho1∆/∆ and 
psd1∆/∆ psd2∆/∆ mutants in a mouse model of systemic infection (Fig. 4.3 A & B).  Indeed, the 
addition of this enzyme fully restored virulence to both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants in the systemic infection model. The differences seen for the survival curve were 
reflected in fungal burden measurements (Fig. 4.3 C).  Although it not clear what is directly 
responsible for this, it is interesting to note that although both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ 
mutants had much lower fungal burden than wild-type, the cho1∆/∆ mutant is diminished more 
than the psd1∆/∆ psd2∆/∆ mutant (Fig. 4.3 C).  This may be attributable to the diminished Als3p 
expression, increased unmasking, or both. 
The Role of Kennedy pathway PE in regulating Als3p and cell wall unmasking 
As Als3p is diminished for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants, it seemed 
likely that PE levels were important for this regulation.  Therefore, Als3p levels were analyzed 
by immunofluorescence for the wild-type and mutant strains expressing AtSDC.  The addition of 
the AtSDC increases Als3p for the psd1∆/∆ psd2∆/∆ mutant, but not the cho1∆/∆ mutant (Fig. 
4.4 A). Relative mean intensity reveals that for Als3p staining, the cho1∆/∆ and cho1∆/∆-AtSDC 
mutants exhibit comparable intensity, while psd1∆/∆ psd2∆/∆-AtSDC is more similar to wild type 
in levels (Fig. 4.4 E).  However, the adhesion to CHO cells seems to be restored for both the 
cho1∆/∆-AtSDC and psd1∆/∆ psd2∆/∆-AtSDC (Fig. 4.4 B). The cho1∆/∆ mutant exposes more 
ß-(1,3) glucan  than wild-type in both yeast and hyphal forms, which leads to increased 
recognition by innate immune cells (83). This effect appears to be mediated solely by the loss of 
PS, as we did not see rescue of ß-(1,3) glucan  unmasking in the cho1∆/∆ mutant by addition of 
AtSDC for either the yeast or the hyphae (Fig. 4.4 C & D).  As Als3p is a known virulence factor 
for the development of orophyrangeal candidiasis (OPC), we tested the in vivo mouse model to 
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determine if addition of the AtSDC gene would affect virulence (31, 63). When the cho1∆/∆-
AtSDC and the psd1∆/∆ psd2∆/∆-AtSDC mutants were tested in this model, virulence was 
restored and there were no statistical differences between these strains and wild type (Fig. 4.5). 
Discussion 
Virulence defects in the cho1∆∆ and psd1∆∆ psd2∆∆ mutants are primarily the products of 
ethanolamine auxotrophy 
 The cho1∆/∆ and psd1∆∆ psd2∆/∆ mutants exhibit a number of phenotypes, but the 
cho1∆/∆ mutant has more substantial cell wall defects than the psd1∆/∆ psd2∆/∆ mutants, 
including greater exposure of ß-(1,3) glucan, and loss of Als3p than psd1∆/∆ psd2∆/∆ (83). This 
has repeatedly raised the question of whether the losses of virulence observed for the cho1∆/∆ 
or psd1∆/∆ psd2∆/∆ mutants are due more to deficiencies in synthesis of PS and PE, or PE 
alone.  The PE synthesis defect is the primary culprit, as both mutants share this in common, 
and the mutants require a minimum of 1mM ethanolamine for growth in culture media and the 
level of ethanolamine in the host is only ~30 µM (44, 156). The observation that AtSDC can 
suppress Als3p expression defects in psd1∆/∆ psd2∆/∆, but not cho1∆/∆ suggests that both PE 
and PS independently regulate Als3p, a surprising and interesting finding. 
 In order to address whether an inability to acquire PE is the result of avirulence for C. 
albicans mutants in the mouse model of disseminated candidiasis, we first heterologously 
expressed in C. albicans the AtSDC, which decarboxylates serine into ethanolamine in the cell’s 
cytoplasm (153). This ethanolamine can then be used by the Kennedy pathway to create PE 
(Fig. 1.1 & 4.1). If virulence is restored for both mutants expressing AtSDC, then this shows that 
insufficient PE synthesis in the host environment due to an inability to acquire enough 
ethanolamine substrate is the main contributor to avirulence.  Synthesis of ethanolamine by 
AtSDC supported growth of the mutants in culture media to levels similar to when they are 
supplemented with 1mM ethanolamine (Fig. 4.2 A & B) and also restored PE levels (Fig. 4.2 C). 
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Finally AtSDC restored virulence in the systemic mouse model based on survival curves and 
fungal burden, and also restored virulence in the OPC model (Fig. 4.3 & 4.5). 
Materials and Methods 
Immunofluorescent Staining of hyphae 
This protocol was modified from a previous publication (83). It is important to note that 
hyphae were induced for AtSDC strains with mouse serum rather than human serum. 
Quantification of Immunofluorescence 
Quantification of LUT’s were performed as previously described (83). 
Immunofluorescence staining for ß-(1,3) glucan  
The method from Davis et al (83) was used, and stationary cultures were stained. 
Hot ethanol extraction and TLC  
Sample extraction and TLC protocols were performed as previously described (44) with 
the following exceptions. Before running with samples, TLC silica gel plates (Fisher cat# 
M1057290001) were prepared by baking them in a drying oven at 100°C for 15 minutes. After 
baking, these plates were run with 50mM EDTA. Plates were then run with a chloroform: 
methanol (1:1) migration solvent to remove EDTA, dried, and baked in the oven again for 15 
minutes.  The samples were then loaded and run as described.  Lipids were visualized on the 
dried plate by spraying with Primuline dye (5mg of Primuline, cat# 206865, Sigma, in 100ml of 
acetone: and visualizing with UV light. 
Mouse systemic infection model 
To prepare strains for injection, 1 O.D. from overnight test tube cultures were washed 5 
times with 1 mL ddH2O then counted by hemacytometer. These washed cultures were then 
diluted to 5*106 cells/ml and 100 µl of cell solution was injected into ICR (Harlan) mice for a total 
of 5*105 yeast/mouse. N=5 mice for each Candida strain. An animal protocol on file with the UT 
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IACUC ensures humane treatment of the animals.  For fungal burdens, cultures were prepared 
and injected the same way as they were for the mouse mortality assay described above. 5 days 
after injection, mice were humanely euthanized, and then both kidneys were removed, one for 
histology and one for CFU counts. The kidney for histology was stored in 10% formaldehyde 
and later sections and stained with H&E by the University of Tennessee Veterinary School. The 
other kidney was weighed and homogenized with a dounce homogenizer in 5 ml ddH2O. This 
homogenate was diluted 1:4 and 200 µl was plated on YPD + 1M sorbitol plates for CFU counts. 
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Appendix. Chapter IV Figures 
 
 
Figure 4.1. Pathways for synthesizing phosphatidylethanolamine in C. albicans.  The 
Kennedy pathway genes are shown in gray, and are named after their predicted homologs in S. 
cerevisiae, and the de novo pathway proteins are shown in white.  Arabidopsis thaliana Serine 
Decarboxylase (AtSDC) is shown in black. Eth: ethanolamine, Cho: choline, Eth-P: 
phosphoethanolamine, Cho-P: phosphocholine, Etn-CDP: cytidyldiphosphate-ethanolamine, 
Cho-CDP: cytidyldiphosphate-choline, PS: phosphatidylserine, PE: phosphatidylethanolamine, 
PC: phosphatidylcholine, CDP-DAG: cytidyldiphosphate-diacylglycerol, Ser: serine. 
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Figure 4.2. Expression of AtSDC restores ethanolamine prototrophy and virulence in 
cho1∆/∆ or psd1∆/∆ psd2∆/∆ in a mouse model of disseminated candidiasis. A,B Mutant 
and wild-type (WT) strains ± AtSDC were grown in minimal media ± ethanolamine (Eth) and a 
growth curve was plotted using OD600 measurements.  C Phospholipids were isolated from 
each strain grown in minimal media lacking ethanolamine, and then separated by TLC.  They 
were visualized with primuline stain under ultraviolet light. 
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Figure 4.3. Expression of AtSDC restores virulence in cho1∆/∆ or psd1∆/∆ psd2∆/∆ in a 
mouse model of disseminated candidiasis. A, B..  Mice were infected by tail-vein with 5x105 
cells from each strain and survival was charted over time. C Mice were infected with 5x105 cells 
by tail-vein and after five days, they were sacrificed, and kidneys were removed, and 
CFUs/gram kidney were counted. * P-value < 0.05, Compared to WT. † P-value <-.05, 
Compared to psd1∆/∆ psd2∆/∆. 
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Figure 4.4. AtSDC restores phenotypes in the psd1∆/∆ psd2∆/∆ mutant, but not cho1∆/∆.  
A The mutant and control strains were induced to form hyphae by serum, and Als3p was 
examined by secondary immunofluorescence using a monoclonal antibody to Als3p as the 
primary.  B  The AtDSC expressing strains were tested for adhesion to CHO cells in tissue 
culture. C The cho1∆/∆ mutant and cho1∆/∆-AtSDC mutant was stained for ß-(1,3) glucan 
exposure with the anti-ß(1-3)-glucan antibody on yeast form. D The cho1∆/∆ mutant and 
cho1∆/∆-AtSDC mutant was stained for ß-(1,3) glucan exposure with the anti-ß(1,3)-glucan 
antibody on hyphal form. E Quantification of Als3p by measuring relative intensity shows Als3p 
levels restored for the psd1∆/∆ psd2∆/∆-AtSDC mutant but not the cho1∆/∆-AtSDC mutant. 
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Figure 4.5. Addition of the AtSDC gene restores virulence in the cho1∆/∆ and psd1∆/∆ 
psd2∆/∆ mutants expressing the serine decarboxylase. There are no statistical differences 
between wild type (WT), cho1∆/∆-AtSDC or psd1∆/∆ psd2∆/∆-AtSDC. 
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Chapter V: Conclusions and Future Directions  
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Conclusions of Dissertation 
Altogether, the findings in this dissertation illustrate how a loss of phosphatidylserine 
(PS) for Candida albicans via the avirulent cho1∆/∆ mutant results in perturbations in the cell 
wall, ultimately resulting in disturbances in the surface which enables ß-(1,3) glucan to become 
exposed on the surface. This polysaccharide can then be recognized by effector cells such as 
macrophages and neutrophils in the host, eliciting an immune response. This is a novel 
phenomenon showing a link between phospholipid synthesis and cell wall construction and/or 
maintenance. 
In addition to a loss of PS, the cho1∆/∆ mutant is reduced in phosphatidylethanolamine 
(PE) levels, a relatively abundant phospholipid. Ultimately the question was to determine 
whether a loss of virulence for the cho1∆/∆ mutant was due to a loss of PS or PE. In order to 
address this, there was a double mutant generated that could not synthesize de novo PE, which 
was the psd1∆/∆ psd2∆/∆ mutant. This mutant was also avirulent, suggesting that PE was 
important for virulence. Since the cho1∆/∆ mutant was shown to have cell wall defects, we 
speculated that this would lead to differences in proteins on the cell surface that may play a role 
in virulence. However studies of these proteins revealed that this may not be the case, although 
there is a difference in the Als3p adhesin protein and a reduction in the oropharyngeal 
candidiasis (OPC) model for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants. 
Although the psd1∆/∆ psd2∆/∆ mutant was avirulent, it was unclear if it was due to 
difficulty with acquiring ethanolamine in the host or if it’s Kenney Pathway was simply 
insufficient to incorporate cellular ethanolamine into PE. By adding the Serine Decarboxylase to 
the strains we were able to reveal that the Kennedy Pathway is more than sufficient to support 
PE synthesis and thus restoring virulence for both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants, 
showing us that the mechanism behind the loss of virulence in these phospholipid synthesis 
mutants is ultimately due to lack of ethanolamine inside the host.
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Future Directions 
Chen et al. discovered that there are significant cell wall aberrations in the cho1∆/∆ 
mutant, but it is unclear how a loss of phospholipids results in cell wall perturbation. It is also 
interesting to note that this phenomenon only seems to occur with the cho1∆/∆ mutant but not 
as much with the psd1∆/∆ psd2∆/∆ mutant, yet both are avirulent and have phospholipid 
deficiencies, suggesting that the loss of phosphatidylserine is specifically responsible for most 
cell wall issues. Our current hypothesis is that the loss of phosphatidylserine affects cell 
signaling beginning at cell surface receptors, ultimately resulting in downstream transcriptional 
regulation that regulate cell wall synthesis. 
There is ample evidence suggesting that the problems that the cho1∆/∆ mutant has with 
cell wall integrity as well as temperature and osmolarity sensitivity (44) are mediated by 
complications of signaling pathways. Data that supports this hypothesis is a western blot 
showing the high osmolarity pathway (HOG pathway) being constitutively activated in the 
cho1∆/∆ mutant but becomes reduced when supplemented with sorbitol, which helps to stabilize 
osmolarity outside of the cell (Fig. A5) (44). This finding correlates with data previously 
generated in our lab, with the cho1∆/∆ mutant having poor growth in regular YPD media but is 
restored when sorbitol is added to the media (44). The HOG pathway as well as the cell wall 
integrity (PCK) pathway are also implicated in cell wall stress, which can be activated by 
osmolarity stress (158). Interestingly, our western blots reveal that the Pkc1p-mediated pathway 
is constitutively activated for the cho1∆/∆ mutant and does not seem to be rescued with any 
addition of sorbitol, which may indicate other factors are at play (Fig. A5). Additionally, the PKC 
pathway can be activated by caspofungin which induces cell wall stress. When the strains are 
stimulated, we see once again that the cho1∆/∆ mutant is constitutively activated but no other 
strains are (Fig. A6). Additionally, under caspofungin stimulation the Hog1p seems to 
phosphorylate less for the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants than the wild type, suggesting 
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that there may be some inverse relationship between activation of the PKC1 and Hog1 
pathways (Fig. A6). Other pathways that may be involved include the CEK pathway, which is 
also known to regulate cell wall reconstruction by regulating the switch from yeast to filamentous 
growth (113, 159). The Cek1p pathway regulates this filamentation by regulation of the GTPase 
Cdc42p, which when active is polarized to the hyphal tip to promote elongation. (113). In 
Saccharomyces cerevisiae, the cho1∆/∆ mutant has a deficiency in Cdc42p polarization, leading 
to delayed bud formation (160). Due to the fact that the cho1∆/∆ mutant has a complete lack of 
PS, the Cdc42p may have difficulties localizing to the proper location on the membrane. We 
have some preliminary evidence that the cho1∆/∆ mutant does not have Cdc42p polarized to 
the hyphae, which also coincides with the cho1∆/∆ mutant developing hyphae slower than our 
other strains in certain growth conditions (44).  
Cdc42p has a sequence of 4 lysine residues near the C-terminus, lending it a general 
positive charge on its surface (161). This positive charge may have interactions with the PS 
located on the inner leaflet of the cell membrane, assisting in co-localization between the PS in 
the membrane of the emerging hyphae and Cdc42p. In order to determine whether Cdc42p mis-
localization is influencing the cell wall architecture of the cho1∆/∆ mutant, a Cdc42p mutant  can 
be designed with targeted mutations in the important Lysine residues, changing them to a less 
positively charged amino acid (such as aspartic acid). This would potentially mimic the absence 
of PS in an otherwise wild-type cell.   Alternatively, a hyperactive allele of Cdc42p, when 
expressed in C. albicans may restore localization in the cho1∆/∆ mutant. If localization is 
restored, the cell wall phenotype of the constitutive mutant will be observed by electron 
microscopy, ß-(1,3) glucan staining and SDS and caspofungin treatment. If Cdc42p also plays a 
role in any cell signaling, Mkc1p activation and Hog1p activation can be tested by western blot. 
However, it is possible that mutations in the Lysine-containing motif do not affect Cdc42p 
localization and its downstream effects. If this is the case, an alternative approach would be to 
73 
 
transform a hyper-active Ste11 into the cho1∆/∆ mutant (162). Ste11 is a Mitogen Activated 
Protein Kinase Kinase Kinase (MAP-KKK) that is activated downstream of Cdc42p, and if active 
can circumvent the issues with Cdc42p localization (163). If addition of this hyper-active Ste11p 
allele by transformation into the cho1∆/∆ mutant reduces cell wall perturbations and sensitivity, it 
would indicate that the Cek1p pathway is involved. 
As the cho1∆/∆ mutant is also the only mutant that we have discovered to have 
increased exposure of ß-(1,3) glucan, future directions will be conducting a large scale 
screening of mutants in various signaling pathways to determine if there are other mutants that 
have this exposure of ß-(1,3) glucan, which would provide stronger evidence that there are 
signaling pathways at play. 
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Table 1. Candida albicans strains 
Strain Parent Genotype Source of Ref. 
SC5314 Clinical isolate Prototrophic Wild Type (164) 
YLC337  cho1Δ/ cho1Δ (44) 
YLC344   cho1Δ/cho1Δ::CHO1-SAT1  (44) 
YLC280  psd1Δ/ psd1Δ (44) 
YLC294  psd1Δ/ psd1Δ::PSD1-SAT1 (44) 
YLC375   psd2Δ/psd2Δ psd1Δ/psd1Δ  (44) 
SED010 SC5314 Wild Type-PENO1-GFP-SAT1 This study 
SED013 YLC337 cho1Δ/ cho1Δ -PENO1-GFP-SAT1 This study 
SED016 YLC280 psd1Δ/ psd1Δ -PENO1-GFP-SAT1 This study 
SED019 YLC375 psd2Δ/psd2Δ psd1Δ/psd1Δ  
  - PENO1-GFP-SAT1 This study 
SED022 YLC344 cho1Δ/Δ::CHO1 with SAT1 flipped out This study 
SED024 SED022 cho1Δ/ cho1Δ::CHO1 -PENO1-GFP-SAT1 This study 
SED025 SC5314 WT::Rim101-V5-SAT1 This study 
SED026 YLC337 cho1∆/cho1∆::Rim101-V5-SAT1 This study 
SED027 YLC280 psd1∆/psd1∆::Rim101-V5-SAT1 This study 
SED028 YLC375 psd2∆/psd2∆  psd1∆/psd1∆::  
 Rim101-V5-SAT1 This study 
SED029 YLC375 psd2∆/psd2∆ psd1∆/psd1∆::PSD1-SAT1 This study 
SED030 SC5314 SC5314::AtSDC::SAT1 This study 
SED031 YLC337 cho1∆/cho1∆::AtSDC::SAT1 This study 
SED032 YLC280 psd1∆/psd1∆::AtSDC::SAT1 This study 
SED033 YLC375 psd2∆/psd2∆  psd1∆/psd1∆  
  ::AtSDC::SAT1 This study 
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Table 2. Primers used in this study 
Primer  Sequence                                   Use                         .                                             
SDO17 aaaaccatggATGGTTGGATCTTTGGAATCTGA AtSDC plasmid  
SDO18 aaaaagatctCTAGACCATGCTCCTACCTAGA AtSDC plasmid 
JCO165        aaagaattcCGTCAAAACTAGAGAATAATAAAG  Rim101p-V5 plasmid 
JCO166 aaagaattcGTTTTCTGGGGAGGGTATTT Rim101p-V5 plasmid 
TRO892 AAAAGGGCCCTTTTGCATCCATAAACAGAGTACA Rim101p-V5 plasmid 
TRO893 AAAACTCGAGAGGTCAAGCTGGTGTGTTGTA Rim101p-V5 plasmid 
SDO20 GTCGTCGTAGTTCAATCC Rim101p-V5 plasmid 
SDO22 aaaaaaACCGGTGGTAAGCCTATCCCTAACCCTCTCC  
 TCGGTCTCGATTCTACGGCAAGTGAGAGTACTGC  Rim101p-V5 plasmid 
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Table 3. Quantification of the Occurrence of Abnormal Hyphae in Mutants 
Strain Cells with Deformity Cells Total Percentage (%) 
SC5314 0 37 0.00% 
cho1Δ/Δ 11 23 47.83% 
cho1::CHO1 0 13 0.00% 
psd1Δ/Δ 0 29 0.00% 
psd1::PSD1 0 19 0.00% 
psd1Δ/Δ psd2Δ/Δ 11 21 52.38%       
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 Appendix. Additional Figures 
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Figure A1. ß-(1,3) glucan and Dectin-1 co-staining immunofluorescence of yeast.  Top 
row panels:  Brightfield optics.  Midde row of panels:  Staining with anti- ß-(1,3) glucan antibody 
and C3 (red) conjugated secondary antibody.  Bottom row of panels:  Staining with sDectin-1-Fc 
and C2 (green) conjugated to secondary antibody. 
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Figure A2. ß-(1,3) glucan and Dectin-1 co-staining immunofluorescence of hyphae. 
Staining illustrates the co-localization of ß-(1,3) glucan staining and binding of the Dectin-1 
receptor. Red = ß-(1,3) glucan. Green = Dectin-1.  
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Figure A3. Hyphae co-staining is comparable between the ß-(1,3) glucan antibody and 
sDectin-1-Fc.  The number of hyphae for a given field of view that stained with ß-(1,3) glucan 
and Dectin-1-Fc were independently divided by the total number of hyphae apparent by bright 
field optics to calculate the percent stained for each fluor.  N=20 per strain. “R” after strain name 
denotes reintegration. 
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Figure A4. ELISA of TNFα elicitation of RAW264.7 macrophages in response to strains 
reveals that only the cho1∆/∆ mutant elicits production, and is mediated by the Dectin-1 
receptor. The cho1∆/∆ mutant is elevated in TNFα elicitation after an 8 hour incubation, and 
this response is reduced to wild type levels when pre-treated with a neutralizing anti-Dectin-1 
antibody. 
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Figure A5. Stimulation of the High Osmolarity Pathway (HOG) with sorbitol reveals the 
cho1∆/∆ mutant is activated differently than wild type. Stimulation reveals that sorbitol 
reduces activation of the HOG pathway via a decrease in Hog1p activation, but does not has an 
effect on the cell wall integrity pathway (mediated by Mkc1p). Also, this western reveals that the 
cell wall integrity pathway is constitutively activate in the cho1∆/∆ mutant. Stimulation was 20 
minutes with 1M sorbitol added to YPD. 
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Figure A6.  Stimulation of the cell wall integrity pathway and Hog1 pathway with 
caspofungin.   When this pathway was stimulated, it was revealed that the cho1∆/∆ mutant’s 
Mkc1p phosphorylation (Mkc2p-P) is constitutively active with or without stimulation, but the 
wild-type, cho1∆/∆ reintegrant (cho1::CHO1) or the psd1∆/∆psd2∆/∆ mutants (p1∆/∆p2∆/∆) do 
not.  Stimulation was 15 minutes with 125 ng caspofungin in YPD media. 
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Materials and Methods 
Protocols pertaining to Appendix Figures A1, A2, A3 and A4 are described in the materials 
method section of Chapter 2. 
Western Blot 
 For both the Hog1p and Mkc1p westerns, the experimental setup were the same. The 
day prior to stimulation, 5 mL of YPD were inoculated from plated strains and incubated 
overnight at 30°C. The next day, these strains were diluted into flasks with 40 mL of fresh YPD 
and grown for 3 hours at 30°C in a shaking incubator. 
For the Hog1p western, the cultures were transferred to conicals and pelleted at 3300 
rpm for 5 minutes. The pellets were then washed in 15 mL ddH2O and pelleted again. After this, 
the pellets were resuspended in 40 mL YPD containing 1mL sorbitol and transferred to new 
flasks. These flasks were then incubated in a 30°C shaking incubator for 20 minutes and then 
pelleted after stimulation. The pellet was then resuspended in protease and phosphatase 
inhibitors (Roche 4906845001) and bead beat and extracted in the same manner as the Rim101 
western mentioned in Chapter 3. SDS-PAGE was run with 20 ug protein, and transferred 
overnight at 10V. Primary antibodies were anti-P-Mkc1p (Cell Signaling Cat #4370), anti-P-
Hog1p (Cell Signaling Cat# 9216), and anti-tubulin (AbD Serotec, cat# MCA78G). Primary 
incubations were performed with antibodies diluted 1:2000 in 5% BSA in TBST and incubated 
overnight at 4°C. Membranes were washed 3X quickly with TBST, then another 2X for 5 
minutes with TBST. Secondary antibodies conjugated to horseradish peroxidase (HRP) were 
then incubated at 1:5000 in 5% with TBST, with anti-rat (for tubulin) (Jackson Immuresearch 
Cat#112-035-175), anti-mouse (for P-Hog1p) (Jackson Immunoresearch Cat# 315-035-008), 
and anti-rabbit (for P-Mkc1p) (Jackson Immunoresearch Cat# 211-032-171) for 20 minutes at 
room temperature. 3 quick washes then 2X 5 minute washes were once again performed in 
TBST. Western blot was developed with Supersignal West Pico Chemiluminescent Substrate 
(Thermo Scientific cat # 34080). 
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For the Mkc1p western, cells were grown to stationary phase overnight in 5mL YPD. The 
next day, strains were diluted to a concentration of 0.1 O.D./mL in 40 mL YPD, and incubated at 
30°C in a shaking incubator for 3 hours. After this time, cells were stimulated with 125 ng/mL 
caspofungin for 10 minutes in a shaking incubator at 30°C (Mitchell 2006). Cells were 
centrifuged at 3300 rpm for 5 minutes and pellets were washed in 10 mL PBS. After washing 
and re-pelleting, cells were resuspended in 100µL of PBS with 1X protease inhibitor (Roche 04-
693-124-001) and 1X phosphatase inhibitor (Roche 04-906-001) and transferred to a screwcap 
microcentrifuge tube. The cell slurry was then bead beat 3X for 1 minute each time, and then 
pelleted at 13000 rpm. Supernatant was then transferred to a new microcentrifuge tube. 
Bradford protein assay was performed to ascertain the total protein, then 20 µg of samples 
suspended in Laemmli buffer were boiled and then separated on 10% acrylamide gels for 90 
minutes at 100 Volts at 4°C, then transferred overnight at 10 Volts at 4°C onto PVDF 
membrane. The next day, membranes were blocked for 1 hour in 5% BSA in TBST. Primary 
antibodies were anti-P-Mkc1p (Cell Signaling Cat #4370), anti-Mkc1p (Cell Signaling Cat# 
9107), anti-P-Hog1p (Cell Signaling Cat# 9216), anti-Hog1p (Santa Cruz Cat# sc-9079), and 
anti-tubulin (AbD Serotec, cat# MCA78G). Primary incubations were performed with antibodies 
diluted 1:2000 in 5% BSA in TBST and incubated for 90 minutes at 4°C. The membranes were 
then quickly washed 3X with TBST, then another 2X for 5 minutes with TBST. Secondary 
antibodies conjugated to horseradish peroxidase (HRP) were then incubated at 1:5000 in 5% 
with TBST, with anti-rat (for tubulin) (Jackson Immuresearch Cat#112-035-175), anti-mouse (for 
P-Hog1p, Hog1p and Mkc1p) (Jackson Immunoresearch Cat# 315-035-008), and anti-rabbit (for 
P-Mkc1p) (Jackson Immunoresearch Cat# 211-032-171) for 20 minutes at room temperature. 3 
quick washes then 2 5 minute washes were once again performed in TBST. Western blot was 
developed with Supersignal West Pico Chemiluminescent Substrate (Thermo Scientific cat # 
34080).  
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